<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2664-3243</journal-id>
<journal-title><![CDATA[Vive Revista de Salud]]></journal-title>
<abbrev-journal-title><![CDATA[Vive Rev. Salud]]></abbrev-journal-title>
<issn>2664-3243</issn>
<publisher>
<publisher-name><![CDATA[CET-BOLIVIA]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2664-32432020000300016</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Aplicación del modelo matemático SEIR en la pandemia por Covid-19, relevancia en salud pública]]></article-title>
<article-title xml:lang="en"><![CDATA[Application of the SEIR mathematical model in the Covid-19 pandemic, relevance in public health]]></article-title>
<article-title xml:lang="pt"><![CDATA[Aplicação do modelo matemático SEIR na pandemia de Covid-19, relevância em saúde pública]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Culqui Sánchez]]></surname>
<given-names><![CDATA[Marco]]></given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nasimba Quinatoa]]></surname>
<given-names><![CDATA[Jaime]]></given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chiliquinga Calderón]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
</contrib>
</contrib-group>
<aff id="A">
<institution><![CDATA[,  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>3</volume>
<numero>9</numero>
<fpage>275</fpage>
<lpage>290</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2664-32432020000300016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2664-32432020000300016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2664-32432020000300016&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Introducción: El pasado 11 de marzo del 2020 la OMS (Organización Mundial para la Salud) realizó la declaratoria de pandemia por Sars-Cov 2, un nuevo coronavirus identificado en China a finales del 2019. Hasta la actualidad el virus se ha diseminado rápidamente en varios países poniendo a prueba los sistemas de salud de los mismos. Los modelos epidemiológicos matemáticos como SEIR (susceptible, expuesto, infectado, removido) han sido utilizados durante años para la gestión y estudio de enfermedades infecciosas. El objetivo: describir las características del modelo matemático SEIR y su aplicación en la gestión de la pandemia con su implicación en las decisiones de salud pública. Metodología: Se realizó una revisión bibliográfica de artículos originales escritos en español o inglés y publicados entre 2015-2020, sobre modelos matemáticos y de tipo SEIR, la relación con las enfermedades infecciosas, la pandemia por Covid-19 e influencia en las decisiones en salud pública. La búsqueda se realizó en las bases de datos google scholar, Medline, Science Direct. No se hicieron restricciones respecto al tipo de estudio. Resultados: El modelamiento matemático para enfermedades infecciosas de tipo SEIR se utiliza como herramienta de predicción para la toma decisiones y deben valorarse objetivamente. Una opción para evaluar las ecuaciones y graficar sus resultados del modelo es el uso del software MATLAB. Conclusión: se destaca su aporte en la comprensión del avance de la pandemia por Covid-19 y la influencia en la toma de decisiones para diseñar estrategias de prevención y respuesta en salud pública.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Introduction: On March 11, 2020, the WHO (World Health Organization) declared a pandemic for Sars-Cov 2, a new coronavirus identified in China at the end of 2019. Until now, the virus has spread rapidly in several countries testing their health systems. Mathematical epidemiological models such as SEIR (susceptible, exposed, infected, removed) have been used for years for the management and study of infectious diseases. Objective: to describe the characteristics of the SEIR mathematical model and its application in pandemic management with its implication in public health decisions. Methodology: A bibliographic review was carried out of original articles written in Spanish or English and published between 2015-2020 on mathematical and SEIR-type models, the relationship with infectious diseases, the Covid-19 pandemic and influence on health decisions public. The search was carried out in the google scholar, Medline, Science Direct databases. There were no restrictions regarding the type of study. Results: Mathematical modeling for infectious diseases of the SEIR type is used as a prediction tool for decision making and should be objectively assessed. One option for evaluating the equations and graphing your model results is to use MATLAB software. Conclusion: their contribution to understanding the progress of the Covid-19 pandemic and the influence on decision-making to design prevention and response strategies in public health is highlighted.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[matemática]]></kwd>
<kwd lng="es"><![CDATA[pandemia por el nuevo coronavirus 2019]]></kwd>
<kwd lng="es"><![CDATA[salud pública]]></kwd>
<kwd lng="en"><![CDATA[mathematics]]></kwd>
<kwd lng="en"><![CDATA[2019 new coronavirus pandemic]]></kwd>
<kwd lng="en"><![CDATA[public health]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">   <b>INVESTIGACI&Oacute;N</b>    <br>    <a href="https://doi.org/10.33996/revistavive.v3i9.66" target="_blank">https://doi.org/10.33996/revistavive.v3i9.66</a></font></p>     <p align="right">&nbsp;</p>     <p align=center><font size="4" face="Verdana, Arial, Helvetica, sans-serif"><b>Aplicaci&oacute;n del modelo matem&aacute;tico SEIR en la pandemia por   Covid-19, relevancia en salud p&uacute;blica </b></font></p>     <p align=center> <font size="4" face="Verdana, Arial, Helvetica, sans-serif"><b></b></font><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>&nbsp; </b></font></p>     <p align=center><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><font size="3">Application of the SEIR mathematical model in the   Covid-19 pandemic, relevance in public health</font></b></font></p>     <p align=center>&nbsp;</p>     <p align=center><font size="3" face="Verdana, Arial, Helvetica, sans-serif"><b><i>Aplica&ccedil;&atilde;o   do modelo matem&aacute;tico SEIR na pandemia de Covid-19, relev&acirc;ncia em sa&uacute;de   p&uacute;blica</i></b></font><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><i></i></b></font></p>     <p align=center>&nbsp;</p>     <p align=center>&nbsp;</p>     ]]></body>
<body><![CDATA[<p align=center><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Marco Culqui S&aacute;nchez<sup>1</sup><a href="" target="_self" onClick="javascript: w = window.open('https://orcid.org/0000&ndash;0002&ndash;8957&ndash;1752','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,'); "><img src="../img/revistas/vrs/v3n9/orcid.png" width="16" height="16" border="0"></a></b>, <b>Jaime Nasimba Quinatoa<sup>2</sup><a href="" target="_self" onClick="javascript: w = window.open('https://orcid.org/0000-0002-4963-9011','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,'); "><img src="../img/revistas/vrs/v3n9/orcid.png" width="16" height="16" border="0"></a></b>, <b>Edgar Chiliquinga Calder&oacute;n<sup>3</sup><a href="" target="_self" onClick="javascript: w = window.open('https://orcid.org/0000&ndash;0003&ndash;3041&ndash;7950','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,'); "><img src="../img/revistas/vrs/v3n9/orcid.png" width="16" height="16" border="0"></a></b>    <br>     <font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><sup>1</sup></b>Hospital       General Jos&eacute; Mar&iacute;a Velasco Ibarra, Ecuador    <br>       <b><sup>2</sup></b>Corporaci&oacute;n       El&eacute;ctrica del Ecuador    <br>         <b><sup>3</sup></b>Instituto de       Seguridad Social de las Fuerzas Armadas del Ecuador    <br>         <b>MC</b>: M&eacute;dico       General- Escuela Polit&eacute;cnica de Chimborazo Ecuador. Diplomado Superior en       Medicina Basada en Evidencia- Universidad Nacional de Colombia. Diplomado       en Investigaci&oacute;n Cient&iacute;fica &ndash; Universidad Aut&oacute;noma de los Andes Ecuador.       Hospital General Jos&eacute; Mar&iacute;a Velasco Ibarra. Ecuador. <a href="mailto:marcoculquisanchez@hotmail.com">marcoculquisanchez@hotmail.com</a>    <br>       <b> JN</b>: Ingeniero       Electr&oacute;nico en Control- Escuela Polit&eacute;cnica de Chimborazo. Master en       Sistemas de Control y Automatizaci&oacute;n - Escuela Polit&eacute;cnica de Chimborazo.       Estudiante doctoral en Ciencias de la ingeniera -Universidad de los Andes       Venezuela. Docente Universitario y Asistente T&eacute;cnico en CELEC EP       Corporaci&oacute;n El&eacute;ctrica Del Ecuador Celec Ep Unidad De Negocios       Transelectric. Ecuador. <a href="mailto:jaimedanielnasimba@outlook.com">jaimedanielnasimba@outlook.com</a>    <br>           <b>ECH</b>: Profesional       m&eacute;dico con 7 a&ntilde;os de experiencia, en el sector p&uacute;blico y privado.&nbsp; Auditor m&eacute;dico de la calidad de       facturaci&oacute;n de los servicios de salud -&nbsp;       ISSFA, desempe&ntilde;e. Funciones en calidad de los servicios de salud,       epidemiologia. Instituto De Seguridad Social De Las Fuerzas Armadas.       Ecuador. <a href="mailto:echiliquinga@issfa.mil.ec">echiliquinga@issfa.mil.ec</a>    <br>           <b>Recibido</b> 01 de octubre 2020 | <b>Arbitrado y aceptado</b>&nbsp;       14 de octubre 2020 | <b>Publicado </b>22 de diciembre 2020 </font> <font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"></font></p>     <p align="justify">&nbsp;</p>     <p align="justify">&nbsp;</p> <hr>     ]]></body>
<body><![CDATA[<p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Resumen </b> </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Introducci&oacute;n: </b>El   pasado 11 de marzo del 2020 la OMS (Organizaci&oacute;n Mundial para la Salud)   realiz&oacute; la declaratoria de pandemia por Sars-Cov 2, un nuevo coronavirus   identificado en China a finales del 2019. Hasta la actualidad el virus se   ha diseminado r&aacute;pidamente en varios pa&iacute;ses poniendo a prueba los sistemas   de salud de los mismos. Los modelos epidemiol&oacute;gicos matem&aacute;ticos como SEIR   (susceptible, expuesto, infectado, removido) han sido utilizados durante   a&ntilde;os para la gesti&oacute;n y estudio de enfermedades infecciosas. El objetivo:   describir las caracter&iacute;sticas del modelo matem&aacute;tico SEIR y su aplicaci&oacute;n en   la gesti&oacute;n de la pandemia con su implicaci&oacute;n en las decisiones de salud   p&uacute;blica. <b>Metodolog&iacute;a</b>: Se realiz&oacute;   una revisi&oacute;n bibliogr&aacute;fica de art&iacute;culos originales escritos en espa&ntilde;ol o   ingl&eacute;s y publicados entre 2015-2020, sobre modelos matem&aacute;ticos y de tipo   SEIR, la relaci&oacute;n con las enfermedades infecciosas, la pandemia por   Covid-19 e influencia en las decisiones en salud p&uacute;blica. La b&uacute;squeda se   realiz&oacute; en las bases de datos google scholar, Medline, Science Direct. No   se hicieron restricciones respecto al tipo de estudio. <b>Resultados:</b> El modelamiento matem&aacute;tico para enfermedades   infecciosas de tipo SEIR se utiliza como herramienta de predicci&oacute;n para la   toma decisiones y deben valorarse objetivamente. Una opci&oacute;n para evaluar   las ecuaciones y graficar sus resultados del modelo es el uso del software   MATLAB. <b>Conclusi&oacute;n:</b> se destaca   su aporte en la comprensi&oacute;n del avance de la pandemia por Covid-19 y la   influencia en la toma de decisiones para dise&ntilde;ar estrategias de prevenci&oacute;n   y respuesta en salud p&uacute;blica.</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palabras   clave:</b> matem&aacute;tica; pandemia por el nuevo coronavirus 2019; salud p&uacute;blica</font></p> <hr>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Abstract </b></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"></font><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Introduction:</b> On March 11, 2020, the WHO (World Health Organization) declared a   pandemic for Sars-Cov 2, a new coronavirus identified in China at the end   of 2019. Until now, the virus has spread rapidly in several countries   testing their health systems. Mathematical epidemiological models such as   SEIR (susceptible, exposed, infected, removed) have been used for years for   the management and study of infectious diseases. <b>Objective:</b> to describe the characteristics of the SEIR   mathematical model and its application in pandemic management with its   implication in public health decisions. <b>Methodology:</b> A bibliographic review was carried out of original   articles written in Spanish or English and published between 2015-2020 on   mathematical and SEIR-type models, the relationship with infectious   diseases, the Covid-19 pandemic and influence on health decisions public.   The search was carried out in the google scholar, Medline, Science Direct   databases. There were no restrictions regarding the type of study. <b>Results:</b> Mathematical modeling for   infectious diseases of the SEIR type is used as a prediction tool for   decision making and should be objectively assessed. One option for   evaluating the equations and graphing your model results is to use MATLAB   software. <b>Conclusion:</b> their   contribution to understanding the progress of the Covid-19 pandemic and the   influence on decision-making to design prevention and response strategies   in public health is highlighted.</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> <b>Key words:</b> mathematics; 2019 new coronavirus pandemic; public health</font></p> <hr>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Resumo </b></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"></font><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Introdu&ccedil;&atilde;o:</b> Em 11 de mar&ccedil;o de 2020, a OMS (Organiza&ccedil;&atilde;o   Mundial da Sa&uacute;de) declarou uma pandemia de Sars-Cov 2, um novo coronav&iacute;rus   identificado na China no final de 2019. At&eacute; agora, o v&iacute;rus se espalhou   rapidamente em v&aacute;rios pa&iacute;ses testando sua sa&uacute;de sistemas. Modelos epidemiol&oacute;gicos   matem&aacute;ticos como o SEIR (suscet&iacute;vel, exposto, infectado, removido) s&atilde;o   usados h&aacute; anos para o gerenciamento e estudo de doen&ccedil;as infecciosas. <b>Objetivo:</b> descrever as   caracter&iacute;sticas do modelo matem&aacute;tico SEIR e sua aplica&ccedil;&atilde;o na gest&atilde;o de   pandemias com sua implica&ccedil;&atilde;o nas decis&otilde;es de sa&uacute;de p&uacute;blica. <b>Metodologia:</b> Foi realizada uma   revis&atilde;o bibliogr&aacute;fica de artigos originais escritos em espanhol ou ingl&ecirc;s   e publicados entre 2015-2020, sobre modelos matem&aacute;ticos e do tipo SEIR, a   rela&ccedil;&atilde;o com doen&ccedil;as infecciosas, a pandemia de Covid-19 e a influ&ecirc;ncia nas   decis&otilde;es de sa&uacute;de p&uacute;blicas. A pesquisa foi realizada nas bases de dados   google scholar, Medline, Science Direct. N&atilde;o houve restri&ccedil;&otilde;es quanto ao   tipo de estudo. Resultados: A modelagem matem&aacute;tica para doen&ccedil;as   infecciosas do tipo SEIR &eacute; utilizada como ferramenta de previs&atilde;o para a   tomada de decis&atilde;o e deve ser avaliada objetivamente. Uma op&ccedil;&atilde;o para   avaliar as equa&ccedil;&otilde;es e representar graficamente os resultados do seu modelo   &eacute; usar o software MATLAB. <b>Conclus&atilde;o:</b> destaca-se a contribui&ccedil;&atilde;o deles para a compreens&atilde;o do progresso da   pandemia Covid-19 e a influ&ecirc;ncia na tomada de decis&otilde;es para a formula&ccedil;&atilde;o   de estrat&eacute;gias de preven&ccedil;&atilde;o e resposta em sa&uacute;de p&uacute;blica.</font></p>     <p align="justify"><font size="2"><b><font face="Verdana, Arial, Helvetica, sans-serif">Palavras-chave</font></b><font face="Verdana, Arial, Helvetica, sans-serif">: matem&aacute;tica; 2019 nova pandemia de coronav&iacute;rus;   sa&uacute;de p&uacute;blica</font></font></p> <hr>     <p align="justify">&nbsp;</p>     ]]></body>
<body><![CDATA[<p align="justify">&nbsp;</p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCCI&Oacute;N </b></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Las enfermedades infecciosas en humanos se encuentran constantemente   relacionadas a brotes ocasionados por coronavirus, incluido el s&iacute;ndrome   respiratorio agudo grave (SARS) en 2002-2003 y el s&iacute;ndrome respiratorio del   Medio Oriente (MERS) en 2012. Se han identificado cuatro coronavirus en humanos   (HKU1, OC43, NL63 y 229E) que tambi&eacute;n se asocian con enfermedades   respiratorias. En China desde el a&ntilde;o 2005 se conocen coronavirus similares al   SARS descritos ampliamente en mam&iacute;feros, incluidos los murci&eacute;lagos, sin embargo   el origen exacto de los coronavirus que infectan humanos sigue sin estar claro   (1). </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La mayor&iacute;a de los coronavirus considerados como pat&oacute;genos   para los humanos se manifiestan con sintomatolog&iacute;a leve, con dos excepciones   notables: el coronavirus del s&iacute;ndrome respiratorio agudo severo (SARS), un beta   coronavirus que surgi&oacute; en noviembre de 2002 al sur de China y que caus&oacute; m&aacute;s de   8000 infecciones humanas y 774 muertes en 37 pa&iacute;ses durante 2002, as&iacute; mismo el   coronavirus del s&iacute;ndrome respiratorio del Medio Oriente (MERS), que fue   detectado por primera vez en 2012 en Arabia Saudita causando 2494 infecciones   humanas , adem&aacute;s de 38 muertes despu&eacute;s de una &uacute;nica introducci&oacute;n en Corea del   Sur (2). </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El 29 de diciembre   de 2019, se identific&oacute; 4 casos reportados de neumon&iacute;a, todos vinculados al   Mercado Mayorista de Mariscos de Huanan (sur de China), identificados por   hospitales locales utilizando un mecanismo de vigilancia para &quot;neumon&iacute;a de   etiolog&iacute;a desconocida&quot; que se estableci&oacute; a ra&iacute;z del brote de s&iacute;ndrome   respiratorio agudo severo (SARS) de 2003 con el objetivo de permitir la identificaci&oacute;n   oportuna de nuevos pat&oacute;genos (3). El 31 de diciembre de 2019 se env&iacute;a un equipo   de respuesta r&aacute;pida &nbsp;por parte del Centro   Chino para el Control y la Prevenci&oacute;n de Enfermedades (CDC de China) con la   finalidad de acompa&ntilde;ar a las autoridades de salud de la provincia de</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Hubei y la ciudad   de Wuhan para realizar una investigaci&oacute;n   epidemiol&oacute;gica y etiol&oacute;gica. Se describi&oacute; un nuevo coronavirus detectado en   pacientes con neumon&iacute;a cuyas muestras fueron analizadas por los CDC de China en   una etapa temprana del brote. (4). El Comit&eacute; Internacional de Taxonom&iacute;a de   Virus (ICTV) design&oacute; a este nuevo virus como SARS-CoV-2, mientras la   Organizaci&oacute;n mundial de la Salud (OMS) public&oacute; el nombre oficial de la   enfermedad causada por este virus, que es COVID-19 (1). </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El Comit&eacute; de Emergencias del Reglamento Sanitario   Internacional de la OMS declar&oacute; que este brote constituye una Emergencia de   Salud P&uacute;blica de Preocupaci&oacute;n Internacional (PHEIC) el 30 de enero de 2020. (5)   El 11 de marzo el director general de la Organizaci&oacute;n Mundial de la Salud   declar&oacute; que ha llegado a la conclusi&oacute;n de que la COVID-19 puede considerarse   una pandemia. (6) Los sistemas de salud p&uacute;blica de todo el mundo fueron puestos   a prueba de tal forma que muchos de ellos colapsaron y la respuesta fue deficiente.</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El modelado matem&aacute;tico puede ser una herramienta &uacute;til   para dise&ntilde;ar estrategias para controlar las enfermedades infecciosas que se   propagan r&aacute;pidamente en ausencia de un tratamiento, vacuna o prueba de   diagn&oacute;stico. </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Este modelo se utiliz&oacute; recientemente para evaluar el potencial   epid&eacute;mico y el control de enfermedades como Zika y Sars-Cov.</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Estos modelos matem&aacute;ticos en la gesti&oacute;n de enfermedades   infecciosas permiten realizar una planificaci&oacute;n sobre todo respecto a los   recursos hospitalarios necesarios en base al n&uacute;mero de casos y al avance propio   de la pandemia. Adem&aacute;s permiten la aplicaci&oacute;n de medidas preventivas y la   consecuente reducci&oacute;n en las variables epidemiol&oacute;gicas.</font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El   presente art&iacute;culo tiene como objetivo principal realizar una explicaci&oacute;n del modelo   matem&aacute;tico SEIR (susceptible, expuesto, infectado, removido) y su utilidad e   influencia en el contexto de la pandemia por Covid-19 en las decisiones en el   campo de salud p&uacute;blica para la gesti&oacute;n adecuada de la misma tanto en los   sistemas de atenci&oacute;n primaria y los m&aacute;s avanzados. </font></p>     <p align="justify">&nbsp;</p>     <p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODO </b></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Se realiz&oacute; una   revisi&oacute;n bibliogr&aacute;fica de art&iacute;culos originales, libros y tesis escritos en   espa&ntilde;ol e ingl&eacute;s publicados entre 2015-2020, sobre modelos matem&aacute;ticos y de   tipo SEIR, la relaci&oacute;n con las enfermedades infecciosas, la pandemia por   Covid-19 e influencia en las decisiones en salud p&uacute;blica. La b&uacute;squeda se   realiz&oacute; en las bases de datos google scholar, Medline, Science Direct con la   siguiente estrategia de b&uacute;squeda: &nbsp;search   (&quot;COVID-19&quot;) AND &ldquo;Seir&rdquo; OR &quot;Models, Statistical&quot;[Mesh]) AND   &quot;Public Health&quot;[Mesh] OR &ldquo;decisions in public health&rdquo;. Se   seleccionaron los publicados en los &uacute;ltimos 5 a&ntilde;os. No se hicieron   restricciones respecto al tipo de estudio.</font></p>     <p align="justify">&nbsp;</p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>DESARROLLO Y DISCUSI&Oacute;N</b></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El SARS-CoV-2 se transmite de forma   similar a la descrita para otros coronavirus principalmente por contacto   directo con gotas de origen respiratorio y las manos o los f&oacute;mites contaminados   con estas secreciones seguido del contacto con la mucosa de la boca, nariz u   ojos, mostrando transmisi&oacute;n de persona a persona, propagaci&oacute;n de agregaci&oacute;n   familiar e infecci&oacute;n nosocomial. La transmisi&oacute;n de SARS-CoV-2 es m&aacute;s diversa de tal forma que se     puede manifestar como una infecci&oacute;n asintom&aacute;tica, algo que no ocurre con las     patolog&iacute;as ocasionadas por los otros coronavirus estudiados como en SARS.     Debido a la ausencia de s&iacute;ntomas, es dif&iacute;cil detectar y aislar los portadores a     tiempo, lo que hace que sea m&aacute;s dif&iacute;cil de controlar la propagaci&oacute;n de la     enfermedad     <!--[if supportFields]><span lang=ES-EC style='font-size: 11.0pt;line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font: major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial; color:black;mso-themecolor:text1;letter-spacing:-.2pt;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;https://doi.org/10.1101/2020.02.20.20025601&quot;,&quot;abstract&quot;:&quot;Importance: In 2002-2003, a severe pulmonary infectious disease occurred in Guangdong, China. The disease was caused by SARS-CoV, 17 years apart, also happen in China, and SARS-CoV-2, this epidemic has posed a significant hazard to people health both China and the whole world. Objective: Summarized the latest epidemiological changes, clinical manifestations, auxiliary examination and pathological characteristics of COVID-19. Evidence Review: PubMed database were searched from 2019 to 2020 using the index terms novel coronavirus or COVID-19 or 2019-nCoV or SARS-CoV-2 and synonyms. Articles that reported clinical characteristics, laboratory results, imageological diagnosis and pathologic condition were included and were retrospectively reviewed for these cases. This paper adopts the method of descriptive statistics. Results: 34 COVID-19-related articles were eligible for this systematic review;Four of the articles were related to pathology. We found that Fever (86.0%), cough (63.9%) and Malaise/Fatigue (34.7%) were the most common symptoms in COVID-19. But in general, the clinical symptoms and signs of COVID-19 were not obvious. Compared with SARS, COVID-19 was transmitted in a more diverse way. The mortality rates of COVID-19 were 2.5%, and the overall infection rate of healthcare worker of COVID-19 was 3.9%. We also found that the pathological features of COVID-19 have greatly similar with SARS, which manifested as ARDS. But the latest pathological examination of COVID-19 revealed the obvious mucinous secretions in the lungs. Interpretation: The clinical and pathological characteristics of SARS and COVID-19 in China are very similar, but also difference. The latest finds of pathological examination on COVID-19 may upend existing treatment schemes, so the early recognition of disease by healthcare worker is very important.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mao&quot;,&quot;given&quot;:&quot;Yaqian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lin&quot;,&quot;given&quot;:&quot;Wei&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wen&quot;,&quot;given&quot;:&quot;Junping&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Chen&quot;,&quot;given&quot;:&quot;Gang&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;medRxiv&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;1-31&quot;,&quot;title&quot;:&quot;Clinical and pathological characteristics of 2019 novel coronavirus disease ( COVID-19 ): a systematic reviews&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=4198b21d-5d9c-46a4-bd52-a5a470322440&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(1)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(1)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(1)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->     (1)   <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt'><span style='mso-element:field-end'></span></span><![endif]-->     . </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El porcentaje de casos que   permanecen asintom&aacute;ticos es del 18% aproximadamente, con un gran potencial de   infecci&oacute;n, independientemente de los hallazgos en tomograf&iacute;a computarizada o   ex&aacute;menes de laboratorio, por su parte los pacientes m&aacute;s j&oacute;venes tienden a   permanecer asintom&aacute;ticos (incluso si est&aacute;n constantemente cerca de un individuo   infectado), mientras que los ancianos generalmente muestran s&iacute;ntomas. Se   calcula &nbsp;que aproximadamente &nbsp;el &nbsp;86% &nbsp;de las infecciones no se han documentado, y   aproximadamente el 55% de esos casos fueron contagiosos. Esto puede deberse al   per&iacute;odo infeccioso que se presenta antes de los s&iacute;ntomas, la frecuencia de los   casos asintom&aacute;ticos y la poca sensibilidad documentada de la prueba para   detecci&oacute;n denominada reacci&oacute;n en cadena de la polimerasa con transcriptasa   inversa (RT-PCR) en muestras nasofar&iacute;ngeas   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt;mso-ansi-language: ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.jcv.2020.104357&quot;,&quot;ISSN&quot;:&quot;18735967&quot;,&quot;PMID&quot;:&quot;32305884&quot;,&quot;abstract&quot;:&quot;Coronavirus disease 2019 is a pandemic influencing the first half of the year 2020. The virus has rapidly spread to many countries. Studies are rapidly published to share information regarding epidemiology, clinical and diagnostic patterns, and prognosis. The following review condenses the surge of information into an organized format.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Siordia&quot;,&quot;given&quot;:&quot;Juan A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal of Clinical Virology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;April&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;104357&quot;,&quot;publisher&quot;:&quot;Elsevier&quot;,&quot;title&quot;:&quot;Epidemiology and clinical features of COVID-19: A review of current literature&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;127&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=62b08a64-09b4-4734-95bc-240d820d825c&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(2)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(2)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(2)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (2)   <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt'><span style='mso-element:field-end'></span></span><![endif]-->   .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El paciente puede transmitir la &nbsp;infecci&oacute;n hasta dos semanas despu&eacute;s de haberse   recuperado de los s&iacute;ntomas de la enfermedad. La transmisi&oacute;n fecal- oral es poco   probable. La transmisi&oacute;n perinatal no ha sido detectada   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt;mso-ansi-language: ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.diagmicrobio.2020.115094&quot;,&quot;ISSN&quot;:&quot;07328893&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ortiz-Prado&quot;,&quot;given&quot;:&quot;Esteban&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Simba&ntilde;a-Rivera&quot;,&quot;given&quot;:&quot;Katherine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;G&oacute;mez-Barreno&quot;,&quot;given&quot;:&quot;Lenin&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rubio-Neira&quot;,&quot;given&quot;:&quot;Mario&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guaman&quot;,&quot;given&quot;:&quot;Linda P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kyriakidis&quot;,&quot;given&quot;:&quot;Nikolaos C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Muslin&quot;,&quot;given&quot;:&quot;Claire&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jaramillo&quot;,&quot;given&quot;:&quot;Ana Mar&iacute;a G&oacute;mez&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Barba-Ostria&quot;,&quot;given&quot;:&quot;Carlos&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cevallos-Robalino&quot;,&quot;given&quot;:&quot;Dom&eacute;nica&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sanches-SanMiguel&quot;,&quot;given&quot;:&quot;Hugo&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Unigarro&quot;,&quot;given&quot;:&quot;Luis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zalakeviciute&quot;,&quot;given&quot;:&quot;Rasa&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gadian&quot;,&quot;given&quot;:&quot;Naomi&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;L&oacute;pez-Cort&eacute;s&quot;,&quot;given&quot;:&quot;Andr&eacute;s&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Diagnostic Microbiology and Infectious Disease&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;,&quot;5&quot;,&quot;30&quot;]]},&quot;page&quot;:&quot;115094&quot;,&quot;publisher&quot;:&quot;Elsevier&quot;,&quot;title&quot;:&quot;Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f889c48d-ee42-34f2-ac0b-f32720dd6c5e&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(3)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(3)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(3)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (3)   <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt'><span style='mso-element:field-end'></span></span><![endif]-->   .</font></p>     <p align="justify"><font size="2"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La fiebre, tos y fatiga se     ]]></body>
<body><![CDATA[    constituyen como caracter&iacute;sticas cl&iacute;nicas dominantes mientras que la         congesti&oacute;n, la rinorrea, el dolor de garganta y la diarrea son poco frecuentes.         Los ni&ntilde;os podr&iacute;an ser menos propensos a infectarse o a su vez si est&aacute;n         infectados pueden presentar s&iacute;ntomas m&aacute;s leves. Tambi&eacute;n se conoce que &nbsp;los &nbsp;&nbsp;ancianos       &nbsp;y aquellos con comorbilidades &nbsp;como &nbsp;&nbsp;diabetes,         hipertensi&oacute;n, enfermedades cardiovasculares, enfermedades hep&aacute;ticas y c&aacute;ncer         ten&iacute;an m&aacute;s probabilidades de desarrollar la enfermedad en estado cr&iacute;tico         <!--[if supportFields]><span     lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     ]]></body>
<body><![CDATA[Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt;mso-ansi-language:     ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN     CSL_CITATION     {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.jinf.2020.03.041&quot;,&quot;ISSN&quot;:&quot;15322742&quot;,&quot;PMID&quot;:&quot;32283155&quot;,&quot;abstract&quot;:&quot;Objective:     To better inform efforts to treat and control the current outbreak with a     comprehensive characterization of COVID-19. Methods: We searched PubMed,     EMBASE, Web of Science, and CNKI (Chinese Database) for studies published as of     March 2, 2020, and we searched references of identified articles. Studies were     reviewed for methodological quality. A random-effects model was used to pool     results. Heterogeneity was assessed using I2. Publication bias was assessed     ]]></body>
<body><![CDATA[using Egger's test. Results: 43 studies involving 3600 patients were included.     Among COVID-19 patients, fever (83.3% [95% CI 78.4&ndash;87.7]), cough (60.3%     [54.2&ndash;66.3]), and fatigue (38.0% [29.8&ndash;46.5]) were the most common clinical     symptoms. The most common laboratory abnormalities were elevated C-reactive     protein (68.6% [58.2&ndash;78.2]), decreased lymphocyte count (57.4% [44.8&ndash;69.5]) and     increased lactate dehydrogenase (51.6% [31.4&ndash;71.6]). Ground-glass opacities (80.0%     [67.3&ndash;90.4]) and bilateral pneumonia (73.2% [63.4&ndash;82.1]) were the most     frequently reported findings on computed tomography. The overall estimated     proportion of severe cases and case-fatality rate (CFR) was 25.6% (17.4&ndash;34.9)     and 3.6% (1.1&ndash;7.2), respectively. CFR and laboratory abnormalities were higher     ]]></body>
<body><![CDATA[in severe cases, patients from Wuhan, and older patients, but CFR did not     differ by gender. Conclusions: The majority of COVID-19 cases are symptomatic     with a moderate CFR. Patients living in Wuhan, older patients, and those with     medical comorbidities tend to have more severe clinical symptoms and higher     CFR.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fu&quot;,&quot;given&quot;:&quot;Leiwen&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wang&quot;,&quot;given&quot;:&quot;Bingyi&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Yuan&quot;,&quot;given&quot;:&quot;Tanwei&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Chen&quot;,&quot;given&quot;:&quot;Xiaoting&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ao&quot;,&quot;given&quot;:&quot;Yunlong&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fitzpatrick&quot;,&quot;given&quot;:&quot;Thomas&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Li&quot;,&quot;given&quot;:&quot;Peiyang&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zhou&quot;,&quot;given&quot;:&quot;Yiguo&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lin&quot;,&quot;given&quot;:&quot;Yi     fan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Duan&quot;,&quot;given&quot;:&quot;Qibin&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Luo&quot;,&quot;given&quot;:&quot;Ganfeng&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fan&quot;,&quot;given&quot;:&quot;Song&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lu&quot;,&quot;given&quot;:&quot;Yong&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Feng&quot;,&quot;given&quot;:&quot;Anping&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zhan&quot;,&quot;given&quot;:&quot;Yuewei&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Liang&quot;,&quot;given&quot;:&quot;Bowen&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cai&quot;,&quot;given&quot;:&quot;Weiping&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zhang&quot;,&quot;given&quot;:&quot;Lin&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Du&quot;,&quot;given&quot;:&quot;Xiangjun&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Li&quot;,&quot;given&quot;:&quot;Linghua&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shu&quot;,&quot;given&quot;:&quot;Yuelong&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zou&quot;,&quot;given&quot;:&quot;Huachun&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal     of     Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;656-665&quot;,&quot;publisher&quot;:&quot;Elsevier     Ltd&quot;,&quot;title&quot;:&quot;Clinical characteristics of coronavirus     disease 2019 (COVID-19) in China: A systematic review and     ]]></body>
<body><![CDATA[meta-analysis&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;80&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=fa3cd472-7589-417f-87fe-8883c22be85c&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(4)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(4)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(4)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->     (4)     <!--[if supportFields]><span     lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt'><span     style='mso-element:field-end'></span></span><![endif]-->     . Adem&aacute;s, los pacientes infectados con COVID-19 desarrollaron s&iacute;ntomas         intestinales como diarrea, solo un bajo porcentaje de pacientes en infecciones     ]]></body>
<body><![CDATA[    humanas por coronavirus como MERS-CoV o SARS-CoV presentaron diarrea     <!--[if supportFields]><span     lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt;mso-ansi-language:     ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN     CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.jaut.2020.102433&quot;,&quot;ISSN&quot;:&quot;10959157&quot;,&quot;PMID&quot;:&quot;32113704&quot;,&quot;abstract&quot;:&quot;Coronavirus     disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of     a potentially fatal disease that is of great global public health concern.     Based on the large number of infected people that were exposed to the wet     ]]></body>
<body><![CDATA[animal market in Wuhan City, China, it is suggested that this is likely the     zoonotic origin of COVID-19. Person-to-person transmission of COVID-19     infection led to the isolation of patients that were subsequently administered     a variety of treatments. Extensive measures to reduce person-to-person     transmission of COVID-19 have been implemented to control the current outbreak.     Special attention and efforts to protect or reduce transmission should be     applied in susceptible populations including children, health care providers,     and elderly people. In this review, we highlights the symptoms, epidemiology,     transmission, pathogenesis, phylogenetic analysis and future directions to control     the spread of this fatal     ]]></body>
<body><![CDATA[disease.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rothan&quot;,&quot;given&quot;:&quot;Hussin     A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Byrareddy&quot;,&quot;given&quot;:&quot;Siddappa     N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal     of     Autoimmunity&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;February&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;102433&quot;,&quot;publisher&quot;:&quot;Elsevier&quot;,&quot;title&quot;:&quot;The     epidemiology and pathogenesis of coronavirus disease (COVID-19)     outbreak&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;109&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=78a2c9c7-13ef-4d4f-be4e-15ba9a947c15&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(5)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(5)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(5)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->     (5)     <!--[if supportFields]><span     ]]></body>
<body><![CDATA[lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt'><span     style='mso-element:field-end'></span></span><![endif]-->     . Una caracter&iacute;stica temprana en pacientes asintom&aacute;ticos sin obstrucci&oacute;n         nasal es la anosmia.     <!--[if supportFields]><span lang=ES-EC     style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt;mso-ansi-language:     ]]></body>
<body><![CDATA[ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN     CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.diagmicrobio.2020.115094&quot;,&quot;ISSN&quot;:&quot;07328893&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ortiz-Prado&quot;,&quot;given&quot;:&quot;Esteban&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Simba&ntilde;a-Rivera&quot;,&quot;given&quot;:&quot;Katherine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;G&oacute;mez-Barreno&quot;,&quot;given&quot;:&quot;Lenin&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rubio-Neira&quot;,&quot;given&quot;:&quot;Mario&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guaman&quot;,&quot;given&quot;:&quot;Linda     P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kyriakidis&quot;,&quot;given&quot;:&quot;Nikolaos     C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Muslin&quot;,&quot;given&quot;:&quot;Claire&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jaramillo&quot;,&quot;given&quot;:&quot;Ana     Mar&iacute;a     G&oacute;mez&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Barba-Ostria&quot;,&quot;given&quot;:&quot;Carlos&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cevallos-Robalino&quot;,&quot;given&quot;:&quot;Dom&eacute;nica&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sanches-SanMiguel&quot;,&quot;given&quot;:&quot;Hugo&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Unigarro&quot;,&quot;given&quot;:&quot;Luis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zalakeviciute&quot;,&quot;given&quot;:&quot;Rasa&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gadian&quot;,&quot;given&quot;:&quot;Naomi&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;L&oacute;pez-Cort&eacute;s&quot;,&quot;given&quot;:&quot;Andr&eacute;s&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Diagnostic     Microbiology and Infectious Disease&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;,&quot;5&quot;,&quot;30&quot;]]},&quot;page&quot;:&quot;115094&quot;,&quot;publisher&quot;:&quot;Elsevier&quot;,&quot;title&quot;:&quot;Clinical,     molecular and epidemiological characterization of the SARS-CoV2 virus and the     Coronavirus disease 2019 (COVID-19), a comprehensive literature     review&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f889c48d-ee42-34f2-ac0b-f32720dd6c5e&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(3)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(3)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(3)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     ]]></body>
<body><![CDATA[style='mso-element:field-separator'></span></span><![endif]-->     (3)     <!--[if supportFields]><span     lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt'><span     style='mso-element:field-end'></span></span><![endif]-->     . Alrededor del 81% del total de los infectados se manifiestan como       casos leves, el 14% graves y el 5% son cr&iacute;ticos       <!--[if supportFields]><span     ]]></body>
<body><![CDATA[lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt;mso-ansi-language:     ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN     CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.jcv.2020.104357&quot;,&quot;ISSN&quot;:&quot;18735967&quot;,&quot;PMID&quot;:&quot;32305884&quot;,&quot;abstract&quot;:&quot;Coronavirus     disease 2019 is a pandemic influencing the first half of the year 2020. The     virus has rapidly spread to many countries. Studies are rapidly published to     share information regarding epidemiology, clinical and diagnostic patterns, and     prognosis. The following review condenses the surge of information into an     organized format.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Siordia&quot;,&quot;given&quot;:&quot;Juan     ]]></body>
<body><![CDATA[A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal     of Clinical     Virology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;April&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;104357&quot;,&quot;publisher&quot;:&quot;Elsevier&quot;,&quot;title&quot;:&quot;Epidemiology     and clinical features of COVID-19: A review of current     literature&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;127&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=62b08a64-09b4-4734-95bc-240d820d825c&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(2)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(2)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(2)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->     (2)     <!--[if supportFields]><span     lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     ]]></body>
<body><![CDATA[Arial;color:black;mso-themecolor:text1;letter-spacing:-.2pt'><span     style='mso-element:field-end'></span></span><![endif]-->     .</font></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Actualmente se realizan pruebas para la detecci&oacute;n del     sars-cov-2 entre las cuales encontramos: PCR de transcripci&oacute;n inversa en tiempo     real en las que las muestras incluyen hisopo nasofar&iacute;ngeo, aspirado traqueal     (si el paciente est&aacute; intubado), lavado bronco alveolar o esputo inducido. La     prueba SARS&#8208;CoV &#8208; 2 RT &#8208; PCR es una     prueba de reacci&oacute;n en cadena de la polimerasa de transcripci&oacute;n inversa en     tiempo real (rRT &#8208;PCR) en la que el ARN     aislado de la muestra se transcribe inversamente en ADNc y luego se amplifica     posteriormente. La presencia de prote&iacute;nas virales (ant&iacute;genos) para SARS-CoV-2     en una muestra del tracto respiratorio de una persona tambi&eacute;n se puede detectar     dentro de los 30 minutos mediante una prueba r&aacute;pida de detecci&oacute;n de ant&iacute;geno.     Si la muestra contiene una concentraci&oacute;n suficiente de prote&iacute;nas virales,     producir&aacute; una se&ntilde;al visualmente detectable al unirse a los anticuerpos     espec&iacute;ficos inmovilizados en una tira de papel. Sin embargo, la sensibilidad de     la prueba var&iacute;a entre 34% y 80%, ya que depende de la concentraci&oacute;n de virus en     la muestra, el tiempo desde el inicio de la enfermedad y la calidad de la     muestra.&nbsp; Otra prueba comercializada para la detecci&oacute;n de SARS-CoV-2 se basa en la </font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">presencia de anticuerpos en el plasma de una persona infectada con     SARS-CoV-2. Sin embargo, la detecci&oacute;n solo es posible en la fase de     recuperaci&oacute;n cuando el paciente comenzar&aacute; a desarrollar una respuesta de     anticuerpos. As&iacute; mismo se describen inconvenientes de reactividad cruzada con     otros pat&oacute;genos y proporciona resultados falsos positivos     <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1002/rmv.2113&quot;,&quot;ISSN&quot;:&quot;1099-1654 (Electronic)&quot;,&quot;PMID&quot;:&quot;32420674&quot;,&quot;abstract&quot;:&quot;The pandemic of 2019 novel coronavirus (SARS-CoV-2019), reminiscent of the<span style='mso-spacerun:yes'>&nbsp; </span>2002-SARS-CoV outbreak, has completely isolated countries, disrupted health systems and partially paralyzed international trade and travel. In order to be better equipped to anticipate transmission of this virus to new regions, it is imperative to track the progress of the virus over time. This review analyses information on progression of the pandemic in the past 3&#8201;months and systematically discusses the characteristics of SARS-CoV-2019 virus including its epidemiologic, pathophysiologic, and clinical manifestations. Furthermore, the review also encompasses some recently proposed conceptual models that estimate the spread of this disease based on the basic reproductive number for better prevention and control procedures. Finally, we shed light on how the virus has endangered the global economy, impacting it both from the supply and demand side.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rafiq&quot;,&quot;given&quot;:&quot;Danish&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Batool&quot;,&quot;given&quot;:&quot;Asiya&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bazaz&quot;,&quot;given&quot;:&quot;M A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Reviews in medical virology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;April&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;e2113&quot;,&quot;title&quot;:&quot;Three months of COVID-19: A systematic review and meta-analysis.&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3f993ab7-92e7-4b07-8208-339b398745b1&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(6)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(6)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(6)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]--> (6) <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1'><span style='mso-element:field-end'></span></span><![endif]--> . </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El n&uacute;mero total global de casos de COVID&#8208;19 ha superado   los 7 millones de casos, infectando a 216 pa&iacute;ses y 431.541 fallecidos al 15 de   junio de 2020   <!--[if supportFields]><span lang=ES-EC style='font-size: 11.0pt;line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font: major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial; color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;URL&quot;:&quot;https://www.who.int/emergencies/diseases/novel-coronavirus-2019&quot;,&quot;accessed&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;,&quot;6&quot;,&quot;15&quot;]]},&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;World Health Organization (WHO)&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;title&quot;:&quot;Enfermedad del coronavirus 2019&quot;,&quot;type&quot;:&quot;webpage&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=8a183038-a6db-39b5-9967-123402c16a4a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(7)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(7)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(7)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (7)   <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1'><span style='mso-element:field-end'></span></span><![endif]-->   .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El n&uacute;mero de reproducci&oacute;n b&aacute;sico (conocido como R 0)     es una medida que cuantifica el potencial epid&eacute;mico de un pat&oacute;geno. Este n&uacute;mero     se define como el n&uacute;mero promedio de las personas infectadas que pueden     transmitir el virus. Basado en epidemias est&aacute;ndar, tener R0 m&aacute;s de 1 podr&iacute;a     conducir a la posible propagaci&oacute;n de una enfermedad. La tasa de reproducci&oacute;n     b&aacute;sica de SARS-CoV-2 oscila entre 2.4 y 3.3, n&uacute;meros que var&iacute;an en relaci&oacute;n con     la movilidad, medidas de contenci&oacute;n, susceptibilidad, poblaci&oacute;n en riesgo entre     otros par&aacute;metros. En este sentido, cada persona infectada por lo tanto     infectar&iacute;a a otras dos o tres personas. El per&iacute;odo de incubaci&oacute;n de COVID-19     generalmente var&iacute;a de 2 a 14 d&iacute;as (98% de los pacientes), con un promedio de 5     d&iacute;as, aunque existen casos con incubaciones de hasta 24 d&iacute;as. El tiempo desde     el inicio de la infecci&oacute;n hasta el desarrollo de una enfermedad grave es una     semana     <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt; line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font:major-latin; mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:black; mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin; mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.diagmicrobio.2020.115094&quot;,&quot;ISSN&quot;:&quot;07328893&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ortiz-Prado&quot;,&quot;given&quot;:&quot;Esteban&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Simba&ntilde;a-Rivera&quot;,&quot;given&quot;:&quot;Katherine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;G&oacute;mez-Barreno&quot;,&quot;given&quot;:&quot;Lenin&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rubio-Neira&quot;,&quot;given&quot;:&quot;Mario&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guaman&quot;,&quot;given&quot;:&quot;Linda P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kyriakidis&quot;,&quot;given&quot;:&quot;Nikolaos C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Muslin&quot;,&quot;given&quot;:&quot;Claire&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jaramillo&quot;,&quot;given&quot;:&quot;Ana Mar&iacute;a G&oacute;mez&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Barba-Ostria&quot;,&quot;given&quot;:&quot;Carlos&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cevallos-Robalino&quot;,&quot;given&quot;:&quot;Dom&eacute;nica&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sanches-SanMiguel&quot;,&quot;given&quot;:&quot;Hugo&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Unigarro&quot;,&quot;given&quot;:&quot;Luis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zalakeviciute&quot;,&quot;given&quot;:&quot;Rasa&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gadian&quot;,&quot;given&quot;:&quot;Naomi&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;L&oacute;pez-Cort&eacute;s&quot;,&quot;given&quot;:&quot;Andr&eacute;s&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Diagnostic Microbiology and Infectious Disease&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;,&quot;5&quot;,&quot;30&quot;]]},&quot;page&quot;:&quot;115094&quot;,&quot;publisher&quot;:&quot;Elsevier&quot;,&quot;title&quot;:&quot;Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f889c48d-ee42-34f2-ac0b-f32720dd6c5e&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(3)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(3)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(3)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]--> (3) <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1'><span style='mso-element:field-end'></span></span><![endif]--> .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">En pa&iacute;ses de todo el mundo se tomaron medidas de   restricci&oacute;n de la movilidad y bloqueos emergentes de tal forma que el efecto   sobre la salud, el bienestar, comercio entre otros aspectos de la cotidianidad   se sienten en las sociedades y en los individuos. Ante la ausencia de   intervenciones farmacol&oacute;gicas efectivas demostradas hasta el momento o vacunas   disponibles en el futuro inminente, reducir la tasa de infecci&oacute;n es una   prioridad   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt; line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font:major-latin; mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:black; mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin; mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/S0140-6736(20)31142-9&quot;,&quot;ISSN&quot;:&quot;1474-547X&quot;,&quot;PMID&quot;:&quot;32497510&quot;,&quot;abstract&quot;:&quot;BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 and is spread person-to-person through close contact. We aimed to investigate the effects of physical distance, face masks, and eye protection on virus transmission in health-care and non-health-care (eg, community) settings. METHODS We did a systematic review and meta-analysis to investigate the optimum distance for avoiding person-to-person virus transmission and to assess the use of face masks and eye protection to prevent transmission of viruses. We obtained data for SARS-CoV-2 and the betacoronaviruses that cause severe acute respiratory syndrome, and Middle East respiratory syndrome from 21 standard WHO-specific and COVID-19-specific sources. We searched these data sources from database inception to May 3, 2020, with no restriction by language, for comparative studies and for contextual factors of acceptability, feasibility, resource use, and equity. We screened records, extracted data, and assessed risk of bias in duplicate. We did frequentist and Bayesian meta-analyses and random-effects meta-regressions. We rated the certainty of evidence according to Cochrane methods and the GRADE approach. This study is registered with PROSPERO, CRD42020177047. FINDINGS Our search identified 172 observational studies across 16 countries and six continents, with no randomised controlled trials and 44 relevant comparative studies in health-care and non-health-care settings (n=25&#8200;697 patients). Transmission of viruses was lower with physical distancing of 1 m or more, compared with a distance of less than 1 m (n=10&#8200;736, pooled adjusted odds ratio [aOR] 0&middot;18, 95% CI 0&middot;09 to 0&middot;38; risk difference [RD] -10&middot;2%, 95% CI -11&middot;5 to -7&middot;5; moderate certainty); protection was increased as distance was lengthened (change in relative risk [RR] 2&middot;02 per m; pinteraction=0&middot;041; moderate certainty). Face mask use could result in a large reduction in risk of infection (n=2647; aOR 0&middot;15, 95% CI 0&middot;07 to 0&middot;34, RD -14&middot;3%, -15&middot;9 to -10&middot;7; low certainty), with stronger associations with N95 or similar respirators compared with disposable surgical masks or similar (eg, reusable 12-16-layer cotton masks; pinteraction=0&middot;090; posterior probability &gt;95%, low certainty). Eye protection also was associated with less infection (n=3713; aOR 0&middot;22, 95% CI 0&middot;12 to 0&middot;39, RD -10&middot;6%, 95% CI -12&middot;5 to -7&middot;7; low certainty). Unadjusted studies and subgroup and sensitivity analyses showed similar findings. INTERPRETATIO&hellip;&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Chu&quot;,&quot;given&quot;:&quot;Derek K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Akl&quot;,&quot;given&quot;:&quot;Elie A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Duda&quot;,&quot;given&quot;:&quot;Stephanie&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Solo&quot;,&quot;given&quot;:&quot;Karla&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Yaacoub&quot;,&quot;given&quot;:&quot;Sally&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sch&uuml;nemann&quot;,&quot;given&quot;:&quot;Holger J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Lancet (London, England)&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;1-15&quot;,&quot;title&quot;:&quot;Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;6736&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=8d6c15ea-5f2c-4b2c-9150-49646dfec1f8&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(8)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(8)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(8)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]--> (8) <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1'><span style='mso-element:field-end'></span></span><![endif]--> .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El modelado sobre COVID-19 planteado en estudios       indic&oacute; de manera consistente un beneficio de las medidas simuladas como es el       caso de cuarentena de personas expuestas a casos confirmados evitando el     ]]></body>
<body><![CDATA[  crecimiento en el n&uacute;mero de infectados y muertes en comparaci&oacute;n con ninguna       medida. La combinaci&oacute;n de la cuarentena con otras medidas de prevenci&oacute;n y       control, como el distanciamiento social, el cierre de instituciones educativas,       la restricci&oacute;n de movilidad interna y externa tuvieron un mayor efecto y una       notable reducci&oacute;n de la transmisi&oacute;n del virus as&iacute; como el requerimiento de       camas de cuidados intensivos y muertes en comparaci&oacute;n con el uso &uacute;nico de       medidas individuales. Las entidades e instituciones encargadas de la toma de       decisiones deben aplicar estrategias de monitoreo constante ante la situaci&oacute;n       del brote y analizar el impacto de las medidas implementadas para mantener el       mejor equilibrio posible sobre las medidas tomadas. La identificaci&oacute;n de     ]]></body>
<body><![CDATA[  pacientes pre o asintom&aacute;ticos dificultan el aislamiento de los casos as&iacute; como       la identificaci&oacute;n de los posibles contactos para ponerlos en cuarentena como       para reducir la transmisibilidad de una forma notable       <!--[if supportFields]><span     lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span     style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION     {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1002/14651858.CD013574.www.cochranelibrary.com&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mayr&quot;,&quot;given&quot;:&quot;V&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ai&quot;,&quot;given&quot;:&quot;Dobrescu&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Chapman&quot;,&quot;given&quot;:&quot;A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Persad&quot;,&quot;given&quot;:&quot;E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Klerings&quot;,&quot;given&quot;:&quot;I&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wagner&quot;,&quot;given&quot;:&quot;G&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Siebert&quot;,&quot;given&quot;:&quot;U&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Christof&quot;,&quot;given&quot;:&quot;C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zachariah&quot;,&quot;given&quot;:&quot;C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gartlehner&quot;,&quot;given&quot;:&quot;G&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mayr&quot;,&quot;given&quot;:&quot;V&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ai&quot;,&quot;given&quot;:&quot;Dobrescu&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Chapman&quot;,&quot;given&quot;:&quot;A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Persad&quot;,&quot;given&quot;:&quot;E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Klerings&quot;,&quot;given&quot;:&quot;I&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wagner&quot;,&quot;given&quot;:&quot;G&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Siebert&quot;,&quot;given&quot;:&quot;U&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Christof&quot;,&quot;given&quot;:&quot;C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zachariah&quot;,&quot;given&quot;:&quot;C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;title&quot;:&quot;measures     to control COVID-19 : a rapid review ( Review     ]]></body>
<body><![CDATA[)&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=9d02f27f-d02e-44b1-8bd5-3491f72e0eec&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(9)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(9)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(9)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->       (9)       <!--[if supportFields]><span     lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1'><span style='mso-element:field-end'></span></span><![endif]-->       .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El distanciamiento f&iacute;sico entre personas est&aacute; asociado       como un factor de protecci&oacute;n cuando se lo realiza al menos a 1 metro, sin     ]]></body>
<body><![CDATA[  embargo la distancia de hasta 2 metros podr&iacute;a ser m&aacute;s efectiva. Se       identificaron entre los pilares fundamentales para evitar la transmisi&oacute;n del       virus al uso obligatorio y generalizado de m&aacute;scaras de tipo N95 o respiradores       similares en entornos de atenci&oacute;n m&eacute;dica y de m&aacute;scaras quir&uacute;rgicas de 12 a 16       capas o de materiales como algod&oacute;n para la comunidad, adem&aacute;s de la protecci&oacute;n       ocular       <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;     line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font:major-latin;     mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:black;     mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;     ]]></body>
<body><![CDATA[mso-field-lock:yes'></span>ADDIN CSL_CITATION     {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/S0140-6736(20)31142-9&quot;,&quot;ISSN&quot;:&quot;1474-547X&quot;,&quot;PMID&quot;:&quot;32497510&quot;,&quot;abstract&quot;:&quot;BACKGROUND     Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19     and is spread person-to-person through close contact. We aimed to investigate     the effects of physical distance, face masks, and eye protection on virus     transmission in health-care and non-health-care (eg, community) settings.     METHODS We did a systematic review and meta-analysis to investigate the optimum     distance for avoiding person-to-person virus transmission and to assess the use     of face masks and eye protection to prevent transmission of viruses. We     obtained data for SARS-CoV-2 and the betacoronaviruses that cause severe acute     ]]></body>
<body><![CDATA[respiratory syndrome, and Middle East respiratory syndrome from 21 standard     WHO-specific and COVID-19-specific sources. We searched these data sources from     database inception to May 3, 2020, with no restriction by language, for     comparative studies and for contextual factors of acceptability, feasibility,     resource use, and equity. We screened records, extracted data, and assessed     risk of bias in duplicate. We did frequentist and Bayesian meta-analyses and     random-effects meta-regressions. We rated the certainty of evidence according     to Cochrane methods and the GRADE approach. This study is registered with     PROSPERO, CRD42020177047. FINDINGS Our search identified 172 observational studies     across 16 countries and six continents, with no randomised controlled trials     ]]></body>
<body><![CDATA[and 44 relevant comparative studies in health-care and non-health-care settings     (n=25&#8200;697 patients). Transmission of viruses was lower with physical     distancing of 1 m or more, compared with a distance of less than 1 m     (n=10&#8200;736, pooled adjusted odds ratio [aOR] 0&middot;18, 95% CI 0&middot;09 to 0&middot;38;     risk difference [RD] -10&middot;2%, 95% CI -11&middot;5 to -7&middot;5; moderate certainty);     protection was increased as distance was lengthened (change in relative risk     [RR] 2&middot;02 per m; pinteraction=0&middot;041; moderate certainty). Face mask use could     result in a large reduction in risk of infection (n=2647; aOR 0&middot;15, 95% CI 0&middot;07     to 0&middot;34, RD -14&middot;3%, -15&middot;9 to -10&middot;7; low certainty), with stronger associations     with N95 or similar respirators compared with disposable surgical masks or     ]]></body>
<body><![CDATA[similar (eg, reusable 12-16-layer cotton masks; pinteraction=0&middot;090; posterior     probability &gt;95%, low certainty). Eye protection also was associated with     less infection (n=3713; aOR 0&middot;22, 95% CI 0&middot;12 to 0&middot;39, RD -10&middot;6%, 95% CI -12&middot;5     to -7&middot;7; low certainty). Unadjusted studies and subgroup and sensitivity     analyses showed similar findings.     INTERPRETATIO&hellip;&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Chu&quot;,&quot;given&quot;:&quot;Derek     K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Akl&quot;,&quot;given&quot;:&quot;Elie     A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Duda&quot;,&quot;given&quot;:&quot;Stephanie&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Solo&quot;,&quot;given&quot;:&quot;Karla&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Yaacoub&quot;,&quot;given&quot;:&quot;Sally&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sch&uuml;nemann&quot;,&quot;given&quot;:&quot;Holger     J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;COVID-19     Systematic Urgent Review Group Effort (SURGE) study     ]]></body>
<body><![CDATA[authors&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Lancet     (London,     England)&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;1-15&quot;,&quot;title&quot;:&quot;Physical     distancing, face masks, and eye protection to prevent person-to-person transmission     of SARS-CoV-2 and COVID-19: a systematic review and     meta-analysis.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;6736&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=8d6c15ea-5f2c-4b2c-9150-49646dfec1f8&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(8)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(8)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(8)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->       (8)       <!--[if supportFields]><span     lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     ]]></body>
<body><![CDATA[mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;color:black;mso-themecolor:text1'><span style='mso-element:field-end'></span></span><![endif]-->       .</font></p>     <p align="justify"><font size="2"><b><font face="Verdana, Arial, Helvetica, sans-serif">Modelo Matem&aacute;tico SEIR</font></b></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Los modelos epidemiol&oacute;gicos matem&aacute;ticos procuran   simular la din&aacute;mica de las enfermedades infecciosas y estiman los par&aacute;metros   relacionados con ella, como la tasa de reproducibilidad, la tasa de mortalidad,   entre otros. El modelo SIR es la forma b&aacute;sica de simulaci&oacute;n y est&aacute; basado en la   probabilidad de que la poblaci&oacute;n se pueda diferenciar en tres grupos (persona   susceptible, infectada y recuperada). Se pueden modificar el n&uacute;mero y tipo de   grupos para reflejar de mejor manera la din&aacute;mica espec&iacute;fica de la enfermedad,   como en el caso de los modelos SEIR (persona susceptible, expuesta, infectada y   recuperada)   <!--[if supportFields]><span lang=ES-EC style='font-size: 11.0pt;line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font: major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial; color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;URL&quot;:&quot;https://es.cochrane.org/es/&iquest;qu&eacute;-ofrecen-los-modelos-matem&aacute;ticos-para-estimar-la-necesidad-de-hospitalizaci&oacute;n-yo-tratamiento-en&quot;,&quot;accessed&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;,&quot;6&quot;,&quot;16&quot;]]},&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Iberoamericano&quot;,&quot;given&quot;:&quot;Centro Cochrane&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;title&quot;:&quot;&iquest;Qu&eacute; ofrecen los modelos matem&aacute;ticos para estimar la necesidad de hospitalizaci&oacute;n y/o tratamiento en las unidades de cuidados intensivos debido a la COVID-19? | Cochrane Iberoam&eacute;rica&quot;,&quot;type&quot;:&quot;webpage&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7459eda3-c6c9-35e9-848d-ea13715aed20&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(10)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(10)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(10)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (10)   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-end'></span></span><![endif]-->   .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Un modelo matem&aacute;tico es formulismo para expresar   relaciones entre variables de un fen&oacute;meno real (epidemia), con la finalidad de   pretender explicar la realidad f&iacute;sica o predecirla. Exceptuando procesos   elementales, los datos obtenidos no van a ser exactos, debido a que el modelo,   inicialmente no puede percibir todas las variables involucradas o integrar   completamente los datos iniciales del fen&oacute;meno en estudio, sin embargo, modelar   la epidemia nos ayuda a estudiar el proceso infeccioso y predecir su evoluci&oacute;n,   con el prop&oacute;sito de conocer la influencia de las medidas introducidas en el   desarrollo de la epidemia con la finalidad de modificar su evoluci&oacute;n   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;15 de marzo de 2020 En matem&aacute;ticas, modelizar es intentar extraer los aspectos significativamente importantes de una situaci&oacute;n real y plasmarlos en forma de expresiones y ecuaciones matem&aacute;ticas. El ob-jetivo, por supuesto, es poner en marcha la maquinaria matem&aacute;tica para intentar explicar la realidad f&iacute;sica o predecirla. Salvo en procesos muy sencillos, lo que se obtenga nunca va a ser exacto, porque el modelo, necesariamente, no puede captar toda la realidad ni todas las variables involucradas, ni incorporar todos los datos iniciales de los que se parte. Pero s&iacute; que puede servir para estudiar el proceso y prever, de alguna forma, c&oacute;mo la introducci&oacute;n de medidas concretas puede hacer que su evoluci&oacute;n futura var&iacute;e. En particular, es lo que ocurre con el desarrollo de las epidemias, y es lo que vamos a inten-tar hacer ahora, mostrando primero el modelo epidemiol&oacute;gico m&aacute;s com&uacute;n (SIR) y otros mejor adaptados a la epidemia de coronavirus COVID-19, como el denominado SEIR, al que incor-poraremos variaciones para poder tener en cuenta las medidas de contenci&oacute;n que se adoptan. Todos estos modelos requieren el uso de ecuaciones sistemas de ecuaciones diferenciales. No intentamos hacer una predicci&oacute;n real con n&uacute;meros concretos (en particular, para ello necesitar&iacute;amos m&aacute;s datos m&eacute;dicos y pol&iacute;ticos de los que nosotros disponemos), sino mostrar la influencia de las medidas en el desarrollo de la epidemia. S&oacute;lo queremos mostrar las tendencias cualitativas-con una explicaci&oacute;n m&aacute;s o menos t&eacute;cnica de las herramientas matem&aacute;ticas que se usan en los c&aacute;lculos y las incertidumbres inherentes al proceso, las mismas que se encuentran todos los epidemi&oacute;logos-, no dar previsiones cuantitativas de c&oacute;mo va a ser el futuro de la epidemia.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guti&eacute;rrez&quot;,&quot;given&quot;:&quot;Jos&eacute; Manuela&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Varona&quot;,&quot;given&quot;:&quot;Juan Luis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Departamento de Matem&aacute;ticas y Computaci&oacute;n Universidad de La Rioja&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;number-of-pages&quot;:&quot;1-14&quot;,&quot;title&quot;:&quot;An&aacute;lisis de la posible evoluci&oacute;n de la epidemia de coronavirus COVID-19 por medio de un modelo SEIR&quot;,&quot;type&quot;:&quot;report&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=734c500b-766d-4adf-93b7-58af8b18656f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(11)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(11)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(11)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (11)   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-end'></span></span><![endif]-->   .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El modelo epidemiol&oacute;gico SEIR es una adaptaci&oacute;n del   modelo SIR propuesto por Karnak y McKendricken en 1927, modelo en el que un   individuo puede asumir de manera excluyente uno de las siguientes estados:   susceptible S, expuesto E, infectado I y removido R, se asume una poblaci&oacute;n   invariable, N = S + E + I + R   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.13140/RG.2.2.12446.89921&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;V&aacute;zquez&quot;,&quot;given&quot;:&quot;Mario&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shin&quot;,&quot;given&quot;:&quot;Hyun Ho&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Luis&quot;,&quot;given&quot;:&quot;Jose&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Noguera&quot;,&quot;given&quot;:&quot;Vazquez&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;March&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;page&quot;:&quot;1-6&quot;,&quot;title&quot;:&quot;Simulaciones con el modelo SEIR del comportamiento epid&eacute;mico del COVID-19 en el departamento de Guair&aacute;-Paraguay Passive Cooling Systems View project Proyecto View project&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=ed046611-5ca3-4f7e-ac96-c2e04588109d&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(12)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(12)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(12)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (12)   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-end'></span></span><![endif]-->   . En general   los individuos susceptibles S, que son infectados se convierten en individuos   expuestos E, y despu&eacute;s del periodo de latencia se transforman en infectados I y   adquieren la capacidad de infectar a otros individuos. Los individuos removidos   R, son los infectados que han sido inmunizados o fallecieron a consecuencia de   la enfermedad   <!--[if supportFields]><span lang=ES-EC style='font-size: 11.0pt;line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font: major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial; color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;ISBN&quot;:&quot;9783642253874&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;&Aacute;vila&quot;,&quot;given&quot;:&quot;Roc&iacute;o&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2016&quot;]]},&quot;title&quot;:&quot;Inferencia de modelos epidemeol&oacute;gicos compartimentales en redes sociales&quot;,&quot;type&quot;:&quot;thesis&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b486a9dc-fb81-466d-a04f-0e28f5da10c7&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(13)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(13)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(13)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (13)   <!--[if supportFields]><span lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;color:black;mso-themecolor:text1;mso-ansi-language:ES-EC'><span style='mso-element:field-end'></span></span><![endif]-->   .</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Espec&iacute;ficamente, la poblaci&oacute;n susceptible S, es el       n&uacute;mero de individuos que pueden ser contagiados por el virus en estudio, se       debe considerar que algunas enfermedades requieren primero de un per&iacute;odo de     ]]></body>
<body><![CDATA[  incubaci&oacute;n durante el cual la enfermedad est&aacute; presente en el organismo, pero no       es contagiosa para los dem&aacute;s, hasta que los primeros s&iacute;ntomas son apreciables,       lo que sucede tras un per&iacute;odo de incubaci&oacute;n (estado latente). La poblaci&oacute;n       expuesta E, est&aacute; conformada por los individuos que han mantenido contacto con       infectados (cercos epidemiol&oacute;gicos), pero que todav&iacute;a no han desarrollado la enfermedad y       todav&iacute;a no son contagiosos       <!--[if supportFields]><span lang=ES-EC     style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:     ]]></body>
<body><![CDATA[yes'></span>ADDIN CSL_CITATION     {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mora&quot;,&quot;given&quot;:&quot;Angel&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;publisher&quot;:&quot;Universidad     de Sevilla&quot;,&quot;title&quot;:&quot;ECON&Oacute;MICAS Y EMPRESARIALES GRADO EN     ECONOM&Iacute;A Ecuaciones diferenciales ordinarias en la modelizaci&oacute;n de procesos     demogr&aacute;ficos     naturales&quot;,&quot;type&quot;:&quot;thesis&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e10a5050-7d31-4dc6-90aa-f58d35e9c5ec&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(14)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(14)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(14)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->       (14)       <!--[if supportFields]><span     lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     ]]></body>
<body><![CDATA[mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;mso-ansi-language:ES-EC'><span style='mso-element:field-end'></span></span><![endif]-->       . La velocidad con que los individuos pasan del       estado latente al estado de infectado se mide con la tasa de exposici&oacute;n (tasa       de contagio) de la poblaci&oacute;n &#963;       <!--[if supportFields]><span     lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:     yes'></span>ADDIN CSL_CITATION     ]]></body>
<body><![CDATA[{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.2105/AJPH.2013.301704&quot;,&quot;abstract&quot;:&quot;En     la primavera del 2009 comenz&oacute; en Am&eacute;rica del Norte la pandemia de gripe por el     virus H1N1, que se propag&oacute; r&aacute;pi&shy; damente por el mundo y suscit&oacute; un gran inter&eacute;s     en las posibles estrategias de miti&shy; gaci&oacute;n para hacer frente a la primera     pandemia de gripe en m&aacute;s de 40 a&ntilde;os. Las investigaciones se centraron en     RESUMEN Evaluamos el uso en la salud p&uacute;blica del n&uacute;mero reproductivo b&aacute;sico (R     0), por el cual se estima la velocidad con que una enfermedad puede propagarse     en una poblaci&oacute;n. Estas estimaciones son de gran inter&eacute;s en el campo de la     salud p&uacute;blica como qued&oacute; de manifiesto en ocasi&oacute;n de la pandemia del 2009 por     el virus gripal A (H1N1). Revisamos los m&eacute;todos usados com&uacute;nmente para estimar     ]]></body>
<body><![CDATA[el R 0 , examinamos su utilidad pr&aacute;ctica y determinamos la forma en que las     estimaciones de este par&aacute;metro epidemiol&oacute;gico pueden servir de fundamento para     tomar decisiones relativas a las estrategias de mitigaci&oacute;n. Por s&iacute; solo, el R 0     es una medida insuficiente de la din&aacute;mica de las enfermedades infecciosas en     las poblaciones; hay otros par&aacute;metros que pueden aportar informaci&oacute;n m&aacute;s &uacute;til.     No obstante, la estimaci&oacute;n del R 0 en una poblaci&oacute;n determinada es &uacute;til para     entender la transmisi&oacute;n de una enfermedad en ella. Si se considera el R 0 en el     contexto de otros par&aacute;metros epidemiol&oacute;gicos importantes, su utilidad puede consistir     en que permite conocer mejor un brote epid&eacute;mico y preparar la respuesta de     salud p&uacute;blica correspondiente. Pan American Journal of Public Health inter     ]]></body>
<body><![CDATA[venciones, como el distanciamiento social, que pudieran aplicarse antes de que     se obtuviera una vacuna monovalente espec&iacute;fica contra el virus H1N1, lo que     ocurri&oacute; en el oto&ntilde;o del 2009. En plena oleada inicial de la pandemia, grupos de     especialistas en modelizaci&oacute;n de todo el mundo comenzaron a reunir datos proce&shy;     dentes de M&eacute;xico para determinar varias caracter&iacute;sticas del virus nuevo (1, 2).     Las actividades se concentraron en la estima&shy; ci&oacute;n r&aacute;pida del n&uacute;mero     reproductivo b&aacute;si&shy; co (R 0) del virus. El R 0 es un par&aacute;metro te&oacute;rico que     proporciona cierta informa&shy; ci&oacute;n acerca de la velocidad con que una enfermedad     puede propagarse en una po&shy; blaci&oacute;n determinada. Las primeras estima&shy; ciones se     publicaron en l&iacute;nea a principios de mayo del 2009 (1, 2). Se siguen publi&shy;     ]]></body>
<body><![CDATA[cando estimaciones del R 0 de otros pa&iacute;ses y a medida que hay m&aacute;s datos (3-11).     Como indicio del inter&eacute;s suscitado por las publicaciones acerca del R 0 , el     art&iacute;culo de Fraser et al., una publicaci&oacute;n tempra&shy; na sobre el potencial     pand&eacute;mico     d&hellip;&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ridenhour&quot;,&quot;given&quot;:&quot;Benjamin&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kowalik&quot;,&quot;given&quot;:&quot;Jessica     M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shay&quot;,&quot;given&quot;:&quot;David     K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Am     J Public     Health&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;32-41&quot;,&quot;title&quot;:&quot;Public     Health     ]]></body>
<body><![CDATA[Applications&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;104&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=a7a01146-18d7-4ecf-874c-d92844d5804a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(15)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(15)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(15)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->       (15)       <!--[if supportFields]><span     lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;mso-ansi-language:ES-EC'><span style='mso-element:field-end'></span></span><![endif]-->       . La poblaci&oacute;n expuesta que desarrolla la       enfermedad se transforma en poblaci&oacute;n infectada I , la rapidez con que los       individuos cambian del estado de infectados a removidos se calcula con la tasa     ]]></body>
<body><![CDATA[  de recuperaci&oacute;n &#947;, la poblaci&oacute;n Removida R, son los individuos que superan       la enfermedad o fallecen       <!--[if supportFields]><span lang=ES-EC     style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;mso-ansi-language:ES-EC'><span style='mso-element:field-begin;mso-field-lock:     yes'></span>ADDIN CSL_CITATION     {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;Ante     la inminente llegada de la pandemia de la enfermedad Covid 19, conocida como     Coronavirus, al territorio ecuatoriano, el Centro de Modelizaci&oacute;n Matem&aacute;tica de     ]]></body>
<body><![CDATA[la Escuela Polit&eacute;cnica Nacional conform&oacute; un equipo de trabajo especializado     para modelizar y simular la propagaci&oacute;n del SARS-CoV-2 (virus causante de la     enfermedad), bajo varios escenarios de pol&iacute;tica p&uacute;blica aplicados a la     contenci&oacute;n del mismo. En este reporte explica- mos los modelos utilizados, las     simulaciones obtenidas y las recomendaciones para mejorar los modelos y, sobre     todo, para el dise&ntilde;o de pol&iacute;ticas p&uacute;blicas que ayuden a minimizar los efectos     negativos de la pandemia en la poblaci&oacute;n, mientras se desarrollan las     actividades productivas esenciales para el     pa&iacute;s&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Castro,     Paula, De los Reyes, Juan Carlos, Gonz&aacute;lez, Sergio, Merino, Pedro,     ]]></body>
<body><![CDATA[Ponce&quot;,&quot;given&quot;:&quot;Joan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Modemat&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;number-of-pages&quot;:&quot;1-13&quot;,&quot;title&quot;:&quot;Modelizaci&oacute;n     y simulaci&oacute;n de la propagaci&oacute;n del virus sars-cov-2 en     Ecuador&quot;,&quot;type&quot;:&quot;report&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=176d93d3-e032-48f9-81c0-5af0bb121837&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(16)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(16)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(16)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span     style='mso-element:field-separator'></span></span><![endif]-->       (16)       <!--[if supportFields]><span     lang=ES-EC style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif";     mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:     Arial;mso-ansi-language:ES-EC'><span style='mso-element:field-end'></span></span><![endif]-->       .</font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Es importante   la asociaci&oacute;n del modelo SEIR para la comprensi&oacute;n con la salud p&uacute;blica por lo   que se presentan los siguientes conceptos:</font></p>     <p align="center"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Tabla1.</b> Par&aacute;metros y conceptos asociados al Modelo SEIR  (15)</font></p>     <p align="center"><img src="../img/revistas/vrs/v3n9/a15_figura01.gif" width="672" height="2052"></p>     <p align="justify"> <font size="2" face="Verdana, Arial, Helvetica, sans-serif">Una caracter&iacute;stica del modelo SEIR, es que considera la poblaci&oacute;n N   constante. La primera ecuaci&oacute;n del modelo SEIR muestra la evoluci&oacute;n en el   tiempo de la poblaci&oacute;n susceptible. Se considera que una persona promedio de la   poblaci&oacute;n susceptible hace contacto suficiente para transmitir la infecci&oacute;n con   &#946;N otras personas por unidad de tiempo, donde N representa el tama&ntilde;o total   de la poblaci&oacute;n. A este efecto se lo conoce como incidencia de acci&oacute;n masiva.   La poblaci&oacute;n susceptible decrece de forma exponencial de acuerdo con la tasa de   transmisi&oacute;n &#946; y el incremento de la poblaci&oacute;n infectada I. La segunda   ecuaci&oacute;n mide la evoluci&oacute;n de la poblaci&oacute;n expuesta E, considerando la   diferencia entre la poblaci&oacute;n susceptible y la poblaci&oacute;n expuesta mediada por   la tasa &#945;. La tercera ecuaci&oacute;n mide la evoluci&oacute;n de la poblaci&oacute;n infectada   I, considerando la diferencia entre los expuestos que eventualmente desarrollar&aacute;n   s&iacute;ntomas y los infectados que se recuperan con tasa &#947;. Por la forma de   segunda y tercera ecuaci&oacute;n, las dos poblaciones, tanto la expuesta como la   infectada, crecen en una primera etapa de forma exponencial, alcanzan un pico,   y descienden de forma tambi&eacute;n exponencial. La cuarta ecuaci&oacute;n muestra la   evoluci&oacute;n de la poblaci&oacute;n removida, la cual crece de acuerdo con la tasa de   recuperaci&oacute;n &#947;.Si la tasa de recuperaci&oacute;n &#947; es mayor a la tasa de transmisi&oacute;n   &#946;, R0 es menor que 1 y se considera que la epidemia puede ser contenida en   un lapso corto de tiempo, lo contario implicar&iacute;a que la enfermedad tiene la   capacidad de extenderse en el tiempo de modo acelerado, la estrategia de   aplanar la curva consiste en disminuir la tasa de contagio &#946; y aumentar la   tasa de recuperaci&oacute;n &#947;, mediante la aplicaci&oacute;n de varias medidas que   ayuden a disminuir velocidad de contagio de la poblaci&oacute;n, para&nbsp; aumentar la proporci&oacute;n de la poblaci&oacute;n que se   recupera o deja de ser susceptible a la enfermedad (desarrollo de medicina y   vacunas, etc.).   <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;letter-spacing:-.25pt'><span style='mso-element:field-begin;mso-field-lock: yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;Ante la inminente llegada de la pandemia de la enfermedad Covid 19, conocida como Coronavirus, al territorio ecuatoriano, el Centro de Modelizaci&oacute;n Matem&aacute;tica de la Escuela Polit&eacute;cnica Nacional conform&oacute; un equipo de trabajo especializado para modelizar y simular la propagaci&oacute;n del SARS-CoV-2 (virus causante de la enfermedad), bajo varios escenarios de pol&iacute;tica p&uacute;blica aplicados a la contenci&oacute;n del mismo. En este reporte explica- mos los modelos utilizados, las simulaciones obtenidas y las recomendaciones para mejorar los modelos y, sobre todo, para el dise&ntilde;o de pol&iacute;ticas p&uacute;blicas que ayuden a minimizar los efectos negativos de la pandemia en la poblaci&oacute;n, mientras se desarrollan las actividades productivas esenciales para el pa&iacute;s&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Castro, Paula, De los Reyes, Juan Carlos, Gonz&aacute;lez, Sergio, Merino, Pedro, Ponce&quot;,&quot;given&quot;:&quot;Joan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Modemat&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2020&quot;]]},&quot;number-of-pages&quot;:&quot;1-13&quot;,&quot;title&quot;:&quot;Modelizaci&oacute;n y simulaci&oacute;n de la propagaci&oacute;n del virus sars-cov-2 en Ecuador&quot;,&quot;type&quot;:&quot;report&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=176d93d3-e032-48f9-81c0-5af0bb121837&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(16)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(16)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(16)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (16)   <!--[if supportFields]><span lang=ES-TRAD style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;letter-spacing:-.25pt'><span style='mso-element:field-end'></span></span><![endif]-->   .</font></p>     <p align="center"><img src="../img/revistas/vrs/v3n9/a15_figura02.gif" width="411" height="388"></p>     <p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Una estrategia de an&aacute;lisis para estimar el valor de la tasa de transmisi&oacute;n   &#946;, consiste en atribuirle distintos valores al n&uacute;mero b&aacute;sico de   reproducci&oacute;n R0, si el periodo de infecci&oacute;n (recuperaci&oacute;n), es conocido el dato   se puede obtener de los individuos que&nbsp;   han superado la enfermedad, si se eval&uacute;a las ecuaciones diferenciales de   acuerdo a la relaci&oacute;n anterior, es posible observar c&oacute;mo cambia la din&aacute;mica del   modelo, y es posible aproximar la curva de infectados I a los&nbsp; casos reportados de la enfermedad en la l&iacute;nea   de tiempo, &nbsp;otra aproximaci&oacute;n consiste&nbsp;   &nbsp;en modificar &nbsp;los &nbsp;par&aacute;metros   &#946; y &nbsp;&nbsp;&#947; con un valor fijo de   R0,&nbsp; aumentar la tasa de transmisi&oacute;n   &#946; y disminuir&nbsp; la tasa de   recuperaci&oacute;n &#947;, el ritmo de propagaci&oacute;n de &nbsp;la epidemia aumenta.   <!--[if supportFields]><span lang=ES style='font-size:11.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: Arial;letter-spacing:-.2pt;mso-ansi-language:ES'><span style='mso-element:field-begin; mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.2105/AJPH.2013.301704&quot;,&quot;abstract&quot;:&quot;En la primavera del 2009 comenz&oacute; en Am&eacute;rica del Norte la pandemia de gripe por el virus H1N1, que se propag&oacute; r&aacute;pi&shy; damente por el mundo y suscit&oacute; un gran inter&eacute;s en las posibles estrategias de miti&shy; gaci&oacute;n para hacer frente a la primera pandemia de gripe en m&aacute;s de 40 a&ntilde;os. Las investigaciones se centraron en RESUMEN Evaluamos el uso en la salud p&uacute;blica del n&uacute;mero reproductivo b&aacute;sico (R 0), por el cual se estima la velocidad con que una enfermedad puede propagarse en una poblaci&oacute;n. Estas estimaciones son de gran inter&eacute;s en el campo de la salud p&uacute;blica como qued&oacute; de manifiesto en ocasi&oacute;n de la pandemia del 2009 por el virus gripal A (H1N1). Revisamos los m&eacute;todos usados com&uacute;nmente para estimar el R 0 , examinamos su utilidad pr&aacute;ctica y determinamos la forma en que las estimaciones de este par&aacute;metro epidemiol&oacute;gico pueden servir de fundamento para tomar decisiones relativas a las estrategias de mitigaci&oacute;n. Por s&iacute; solo, el R 0 es una medida insuficiente de la din&aacute;mica de las enfermedades infecciosas en las poblaciones; hay otros par&aacute;metros que pueden aportar informaci&oacute;n m&aacute;s &uacute;til. No obstante, la estimaci&oacute;n del R 0 en una poblaci&oacute;n determinada es &uacute;til para entender la transmisi&oacute;n de una enfermedad en ella. Si se considera el R 0 en el contexto de otros par&aacute;metros epidemiol&oacute;gicos importantes, su utilidad puede consistir en que permite conocer mejor un brote epid&eacute;mico y preparar la respuesta de salud p&uacute;blica correspondiente. Pan American Journal of Public Health inter venciones, como el distanciamiento social, que pudieran aplicarse antes de que se obtuviera una vacuna monovalente espec&iacute;fica contra el virus H1N1, lo que ocurri&oacute; en el oto&ntilde;o del 2009. En plena oleada inicial de la pandemia, grupos de especialistas en modelizaci&oacute;n de todo el mundo comenzaron a reunir datos proce&shy; dentes de M&eacute;xico para determinar varias caracter&iacute;sticas del virus nuevo (1, 2). Las actividades se concentraron en la estima&shy; ci&oacute;n r&aacute;pida del n&uacute;mero reproductivo b&aacute;si&shy; co (R 0) del virus. El R 0 es un par&aacute;metro te&oacute;rico que proporciona cierta informa&shy; ci&oacute;n acerca de la velocidad con que una enfermedad puede propagarse en una po&shy; blaci&oacute;n determinada. Las primeras estima&shy; ciones se publicaron en l&iacute;nea a principios de mayo del 2009 (1, 2). Se siguen publi&shy; cando estimaciones del R 0 de otros pa&iacute;ses y a medida que hay m&aacute;s datos (3-11). Como indicio del inter&eacute;s suscitado por las publicaciones acerca del R 0 , el art&iacute;culo de Fraser et al., una publicaci&oacute;n tempra&shy; na sobre el potencial pand&eacute;mico d&hellip;&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ridenhour&quot;,&quot;given&quot;:&quot;Benjamin&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kowalik&quot;,&quot;given&quot;:&quot;Jessica M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shay&quot;,&quot;given&quot;:&quot;David K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Am J Public Health&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;32-41&quot;,&quot;title&quot;:&quot;Public Health Applications&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;104&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=a7a01146-18d7-4ecf-874c-d92844d5804a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(15)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(15)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(15)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span style='mso-element:field-separator'></span></span><![endif]-->   (15)   <!--[if supportFields]><span lang=ES style='font-size: 11.0pt;line-height:115%;font-family:"Cambria","serif";mso-ascii-theme-font: major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial; letter-spacing:-.2pt;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--> </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Si se conoce el valor de las distintas tasas o periodos involucrados en el   modelo, se puede calcular directamente el valor de R0 y evaluar las ecuaciones   diferenciales. </font></p>     <p align="center"><img src="../img/revistas/vrs/v3n9/a16_figura01.png" width="501" height="393"></p>     <p align="center"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><i>Figura </i>1.</b> Din&aacute;mica de un modelo   SEIR      (19) </font></p>     <p align="left"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La din&aacute;mica que describen las ecuaciones del modelo SEIR es:</font></p>     ]]></body>
<body><![CDATA[<blockquote>       <blockquote>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1.&nbsp;&nbsp;&nbsp;       En &nbsp;un&nbsp; &nbsp;inicio &nbsp;todos &nbsp;&nbsp;los       &nbsp;individuos &nbsp;est&aacute;n libres de enfermedades y son       susceptibles (S) a la infecci&oacute;n con COVID-19. </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2.&nbsp;&nbsp;&nbsp;       Despu&eacute;s       de que se introduce COVID-19 en la poblaci&oacute;n, las personas susceptibles que estuvieron       expuestas (E) al virus se enferman y aumenta el n&uacute;mero de individuos infectados       (I), lo que aumenta en el n&uacute;mero de personas que se recuperan (R) o fallecen </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3.&nbsp;&nbsp;&nbsp;       Eventualmente,       a medida que la enfermedad se abre paso a trav&eacute;s de la poblaci&oacute;n, el n&uacute;mero de       individuos que se recuperan (R) de la enfermedad superar&aacute; en n&uacute;mero a aquellos       que a&uacute;n no la han contra&iacute;do (S). </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4.&nbsp;&nbsp;&nbsp;       El       brote termina cuando no hay suficientes individuos susceptibles para mantener       una mayor propagaci&oacute;n de la enfermedad.              (20)            </font></p>   </blockquote> </blockquote>     <p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Una alternativa para evaluar las relaciones matem&aacute;ticas y observar de   manera gr&aacute;fica la din&aacute;mica del modelo SEIR es codificar un algoritmo en el   software MATLAB (MATrix LABoratory), sistema de c&oacute;mputo num&eacute;rico que ofrece un   entorno de desarrollo integrado (IDE) usa un lenguaje de programaci&oacute;n propio   (lenguaje M) y est&aacute; disponible para las plataformas Unix, Windows, macOS y   GNU/Linux, el&nbsp; programa permite la   manipulaci&oacute;n de matrices,&nbsp; representaci&oacute;n   de datos y funciones, la implementaci&oacute;n de algoritmos y creaci&oacute;n de interfaces   de usuario (GUI), es un software muy usado en universidades y centros de   investigaci&oacute;n y desarrollo por su versatilidad.</font></p>     <p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Aplicaci&oacute;n en las decisiones de salud p&uacute;blica asociadas a   la pandemia por Covid-19 </b></font></p>     <p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La aplicaci&oacute;n central para elaborar y analizar modelos matem&aacute;ticos es   mejorar el entendimiento de una epidemia y coadyuvar a tomar decisiones   objetivas para controlar o erradicar en lo posible las enfermedades,   incrementando el tiempo de recuperaci&oacute;n de la poblaci&oacute;n, lo que tendr&iacute;a un   efecto de descenso de la tasa de infecci&oacute;n, el uso de vacunas reduce la   poblaci&oacute;n susceptible inicial, un per&iacute;odo latente prolongado corresponde a un   peque&ntilde;o valor del tiempo de incubaci&oacute;n.</font></p>     <p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El modelamiento matem&aacute;tico para enfermedades infecciosas se utiliza como   herramienta en la toma decisiones y debe valorarse objetivamente, un problema   es dif&iacute;cilmente comprensible sin una m&iacute;nima modelaci&oacute;n, no obstante, debemos   conocer que el modelamiento de todas las situaciones reales no es posible.</font></p>     ]]></body>
<body><![CDATA[<p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El R0, proporciona informaci&oacute;n   de la velocidad con que una enfermedad puede propagarse en una poblaci&oacute;n   determinada, es decir el potencial de la transmisi&oacute;n sin ninguna intervenci&oacute;n,   porque a partir del valor umbral de 1,0 puede indicar cu&aacute;ndo podr&iacute;a ocurrir un   brote&nbsp; o un R0 de 2 o 4&#8805; indica que   hay un contagio acelerado y significativo, en d&oacute;nde cada persona contagia en un   d&iacute;a a otras dos o cuatro, volvi&eacute;ndose un factor exponencial      (15)      .</font></p>     <p align=justify><font size="2" face="Verdana, Arial, Helvetica, sans-serif">En &eacute;ste sentido si el n&uacute;mero   de reproducci&oacute;n efectiva, Re = R0 x (S/N), es superior que 1, 0, nos har&aacute;   esperar que la enfermedad contin&uacute;e con la propagaci&oacute;n; la reproducci&oacute;n efectiva   refleja que mientras que la proporci&oacute;n de individuos susceptibles disminuye, la   tasa de trasmisi&oacute;n de la enfermedad se vuelve m&aacute;s lenta. </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">En &eacute;ste contexto se tomar&aacute; en cuenta el   n&uacute;mero reproductivo b&aacute;sico es un par&aacute;metro importante para determinar el   control de una epidemia      . </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Para detener la propagaci&oacute;n   del virus se realizan estrategias de mitigaci&oacute;n que:</font></p>     <blockquote>       <blockquote>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">-&nbsp;&nbsp;&nbsp;&nbsp;       Disminuyan el R0 mediante el cambio de la tasa de       transmisi&oacute;n (cierres de fronteras, aeropuertos, centros educativos, etc.) o de       la duraci&oacute;n de la infecciosidad (el uso de antiretroviral de forma temprana). </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">-&nbsp;&nbsp;&nbsp;&nbsp;       Disminuyan el Re reduciendo el n&uacute;mero de individuos       susceptibles (por ejemplo, mediante la vacunaci&oacute;n). </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">-&nbsp;&nbsp;&nbsp;&nbsp;       Actuando en &#945; que es tasa de contacto       efectivo, mediante lavado de manos, distanciamiento social, medidas de       biosedeguridad, cuarentena etc. </font></p>   </blockquote> </blockquote>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Modelos epidemiol&oacute;gicos para el abordaje de la pandemia COVID-19</b></font></p>     ]]></body>
<body><![CDATA[<blockquote>       <blockquote>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">- <b>El modelo 1:</b> &ldquo;contagio total&rdquo;; consideraron una enfermedad gripal, con un gran       porcentaje de asintom&aacute;ticos y que las tasas de letalidad y mortalidad del virus       eran bajas. </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">- <b>El modelo 2:</b> las cuarentenas generalizadas, como segunda estrategia para el abordaje       de la pandemia. Los cierres totales afectaban significativamente a las       econom&iacute;as m&aacute;s vulnerables e informales; y a la vez, debilitaba las relaciones       comerciales. La mayor&iacute;a de pa&iacute;ses, como es de esperar, antepuso la salud a la       econom&iacute;a, pero la pandemia sigue. </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">- <b>El modelo 3:</b> la pandemia de COVID-19 es un problema &ldquo;social&rdquo;. En efecto, el       SARS-CoV-2 es un virus gripal pero el dinamismo y la velocidad de contagio (R0)       depende del distanciamiento social y evitar que los micros gotas de saliva       (flugge) de un sujeto alcancen a otro. El uso de mascarillas adecuadas, higiene       y distanciamiento social representan el tercer m&eacute;todo de abordaje. El problema       de este enfoque son las malas pr&aacute;cticas recurrentes, el uso inadecuado de       mascarilla, el descuido y sobre todo la falta de conciencia, ya que el 60% de       los contagiados son asintom&aacute;ticos. </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> - <b>El modelo 4: </b>un cuarto enfoque o m&eacute;todo es el de los cercos epidemiol&oacute;gicos de campo       o social focalizados. En este modelo, la epidemiolog&iacute;a tradicional persigue los       focos de contagio y los a&iacute;sla de modo comunitario por 15 d&iacute;as. Es un modelo con       mucha fuerza y buenos resultados; no obstante, demanda esfuerzos territoriales       de gran envergadura ya que deben hacerse muchas visitas y desplegar equipos       sanitarios locales. Este modelo parte de un primer de nivel de atenci&oacute;n robusto       y de equipos locales de trabajo coordinados con los niveles centrales. </font></p>         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">- <b>El modelo 5:</b> aplicar el &ldquo;Problema de los puentes de K&ouml;nigsberg&rdquo; o teor&iacute;a de grafos;       &iquest;cu&aacute;l es la idea?, no restringir la libertad de movimiento, pero s&iacute;       complicarla; es decir, cerrar ciertos accesos t&iacute;picos a ciudades para que la       poblaci&oacute;n tenga que viajar m&aacute;s para llegar a un destino              (21)              . </font></p>   </blockquote> </blockquote>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Modelo hospitalario</b></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Las entradas al modelo incluyen estimaciones de las caracter&iacute;sticas de   la poblaci&oacute;n de pacientes y la capacidad hospitalaria. Las entradas de la   poblaci&oacute;n de pacientes son la poblaci&oacute;n inicial de pacientes con COVID-19-,   pacientes con COVID-19 + y el tiempo de duplicaci&oacute;n estimado para las   admisiones totales de COVID-19 (es decir, cu&aacute;ntos d&iacute;as se necesitar&aacute;n para que   el n&uacute;mero total de admisiones en la instituci&oacute;n a duplicar).</font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El primer d&iacute;a de la simulaci&oacute;n (d&iacute;a 0) es fijo. Para cada d&iacute;a posterior,   el modelo utiliza el n&uacute;mero proyectado de pacientes con COVID-19, divide a los   pacientes en cohortes y actualiza el n&uacute;mero de pacientes con COVID-19 que   requieren camas de CI (cama de cuidado intensivo) y AC (camas de cuidado   agudo): </font></p> </p></p>     ]]></body>
<body><![CDATA[<blockquote>         <blockquote>           <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>1.&nbsp;&nbsp; </b> Admisiones COVID-19: Proyectamos las admisiones con un modelo de         crecimiento exponencial Utilizando datos basados en los primeros 14 d&iacute;as de         admisiones de pacientes (el n&uacute;mero total de pacientes admitidos hasta el d&iacute;a n         es el producto del n&uacute;mero de pacientes ingresados hasta el d&iacute;a 0 y 2 a la         potencia de n dividida por el tiempo de duplicaci&oacute;n). </font></p>           <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>2.&nbsp;&nbsp; </b> Cohortes de pacientes: Los pacientes se dividen en 5 cohortes de         atenci&oacute;n: Las cohortes 1 (piso) y 5 (UCI) son pacientes que pasan tiempo solo.         Las 3: 2 (piso-uci-piso), 3 (UCI) y 4 (uci-piso) son pacientes que pasan tiempo         en una unidad de CI, solo antes, solo despu&eacute;s, o ambos antes y despu&eacute;s de pasar         tiempo en una unidad de cuidado agudo. </font></p>           <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>3.&nbsp;&nbsp; </b> Duraci&oacute;n de la estad&iacute;a en la cohorte: Cada paciente de cada cohorte pasa         el n&uacute;mero de d&iacute;as especificado por las entradas de los par&aacute;metros en las         unidades IC y AC. El censo total en cada una de las unidades de CI y CA de cada         d&iacute;a se calcula como la suma de los pacientes que llegaron a esa unidad menos la         suma de los pacientes que han sido dados de alta de esa unidad. </font></p>           <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>4.&nbsp;&nbsp; </b> Requisitos proyectados de camas de CI: la cantidad de camas de CI         requeridas cada d&iacute;a es la suma de la cantidad de pacientes con COVID-19 + y         COVID-19-CI. </font></p>           <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>5.&nbsp;&nbsp; </b> Requisitos proyectados del equipo m&eacute;dico COVID-19: El n&uacute;mero de         pacientes a ser atendidos por el Servicio M&eacute;dico cada d&iacute;a es la suma del n&uacute;mero         de pacientes COVID-19 + AC y pacientes COVID-19- atendidos por el Servicio de         Medicina. </font></p>           <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>6.&nbsp;&nbsp; </b> Requisitos proyectados de cama CA: el n&uacute;mero de camas de cuidados agudo         necesarias cada d&iacute;a, es la suma del n&uacute;mero de pacientes con COVID-19 + y         COVID-19-AC. </font></p>           <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>7.&nbsp;&nbsp; </b> Requisitos del ventilador: El n&uacute;mero de ventiladores necesarios se         estima como la suma del 50% de los pacientes con CI sin COVID-19 y el 100% de         los pacientes con COVID-19+ pacientes CI.                (22)                (23)                . </font></p>     </blockquote> </blockquote>       <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La proyecci&oacute;n del n&uacute;mero de     casos en base al modelo matem&aacute;tico SEIR permite una respuesta en base a la     planificaci&oacute;n que permite gestionar los recursos humanos, materiales,     infraestructura hospitalaria, as&iacute; como acciones en el primer nivel de atenci&oacute;n. </font></p>       ]]></body>
<body><![CDATA[<p align=justify>&nbsp;</p>       <p align=justify><font size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUSI&Oacute;N </b></font></p>       <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Los     modelos matem&aacute;ticos como el SEIR podr&iacute;an ser &uacute;tiles en la administraci&oacute;n de     salud p&uacute;blica debido a que adem&aacute;s de facilitar la comprensi&oacute;n del curso la     pandemia por Covid-19 a trav&eacute;s de la proyecci&oacute;n simulada de casos, permite la     planificaci&oacute;n de recursos: humanos, infraestructura, insumos y medicamentos,     tanto en el primer nivel de atenci&oacute;n como a nivel hospitalario. La utilizaci&oacute;n     del mismo, a trav&eacute;s de programas inform&aacute;ticos o aplicaciones web, podr&iacute;a ser     implementada en todos los sistemas de salud del mundo. Se sugiere continuar     investigando la efectividad del uso del modelo matem&aacute;tico SEIR as&iacute; como otros     utilizados con frecuencia. Este modelo &nbsp;puede beneficiar la gesti&oacute;n oportuna y las     decisiones en salud p&uacute;blica en el contexto de     la pandemia por Covid-19 y futuras enfermedades infecciosas de importancia global.</font></p>       <p align="justify">&nbsp; </p>       <p align=justify><font size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCIAS BIBLIOGR&Aacute;FICAS </b></font></p>       <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">          <b>1.</b> &nbsp;&nbsp;&nbsp; Mao Y, Lin     W, Wen J, Chen G. Clinical and pathological characteristics of 2019 novel     coronavirus disease ( COVID-19 ): a systematic reviews. medRxiv. 2020;1&ndash;31 </font></p>       <!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>2.&nbsp;&nbsp;&nbsp;&nbsp; </b>Siordia JA. Epidemiology and clinical features of     COVID-19: A review of current literature. J Clin Virol [Internet].     2020;127(April):104357. Available from: <a href="https://doi.org/10.1016/j.jcv.2020.104357" target="_blank"> <a href="https://doi.org/10.1016/j.jcv.2020.104357" target="_blank">https://doi.org/10.1016/j.jcv.2020.104357</a></font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312689&pid=S2664-3243202000030001600002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>3.</b>&nbsp;&nbsp;&nbsp;&nbsp; Ortiz-Prado E, Simba&ntilde;a-Rivera K,     G&oacute;mez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical,     molecular and epidemiological characterization of the SARS-CoV2 virus and the     Coronavirus disease 2019 (COVID-19), a comprehensive literature review. Diagn     Microbiol Infect Dis [Internet]. 2020 May 30 [cited 2020 Jun 15];115094.     Available from: <a href="https://linkinghub.elsevier.com/retrieve/pii/S0732889320304715" target="_blank"><a href="https://linkinghub.elsevier.com/retrieve/pii/S0732889320304715" target="_blank">https://linkinghub.elsevier.com/retrieve/pii/S0732889320304715</a></font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312690&pid=S2664-3243202000030001600003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>4.</b>&nbsp;&nbsp;&nbsp;&nbsp; Fu L, Wang B, Yuan T, Chen X, Ao     Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019     (COVID-19) in China: A systematic review and meta-analysis. J Infect     [Internet]. 2020;80(6):656&ndash;65. Available from: <a href="https://doi.org/10.1016/j.jinf.2020.03.041" target="_blank"><a href="https://doi.org/10.1016/j.jinf.2020.03.041" target="_blank">https://doi.org/10.1016/j.jinf.2020.03.041</a></font></p>       <!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>5. </b>Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus     disease (COVID-19) outbreak. J Autoimmun [Internet]. 2020;109(February):102433.     Available from: <a href="https://doi.org/10.1016/j.jaut.2020.102433" target="_blank">https://doi.org/10.1016/j.jaut.2020.102433</a></font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312692&pid=S2664-3243202000030001600005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>6.</b> &nbsp;&nbsp;&nbsp; Rafiq D, Batool A, Bazaz MA.     Three months of COVID-19: A systematic review and meta-analysis. Rev Med Virol.     2020;(April):e2113</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312693&pid=S2664-3243202000030001600006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>7.&nbsp;&nbsp;&nbsp;&nbsp; </b>World Health Organization (WHO). Enfermedad del     coronavirus 2019 [Internet]. 2020 [cited 2020 Jun 15]. Available from: <a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019" target="_blank">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</a></font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312694&pid=S2664-3243202000030001600007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>8.&nbsp;&nbsp;&nbsp;&nbsp; </b>Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Sch&uuml;nemann     HJ, et al. Physical distancing, face masks, and eye protection to prevent     person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review     and meta-analysis. Lancet (London, England) [Internet]. 2020;6736(20):1&ndash;15.     Available from: <a href="http://www.ncbi.nlm.nih.gov/pubmed/32497510" target="_blank"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32497510" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/32497510</a></font></p>       <!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>9.</b>&nbsp;&nbsp;&nbsp;&nbsp; Mayr V, Ai D, Chapman A, Persad     E, Klerings I, Wagner G, et al. measures to control COVID-19&#8239;: a rapid     review ( Review ). 2020</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312696&pid=S2664-3243202000030001600009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>10.</b> Iberoamericano CC. &iquest;Qu&eacute; ofrecen los modelos matem&aacute;ticos para estimar la     necesidad de hospitalizaci&oacute;n y/o tratamiento en las unidades de cuidados     intensivos debido a la COVID-19? | Cochrane Iberoam&eacute;rica     [Internet]. 2020 [cited 2020 Jun 16]. Available from: <a href="https://es.cochrane.org/es/&iquest;qu&eacute;-ofrecen-los-modelos-matem&aacute;ticos-para-estimar-la-necesidad-de-hospitalizaci&oacute;n-yo-tratamiento-en" target="_blank">https://es.cochrane.org/es/&iquest;qu&eacute;-ofrecen-los-modelos-matem&aacute;ticos-para-estimar-la-necesidad-de-hospitalizaci&oacute;n-yo-tratamiento-en</a></font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312697&pid=S2664-3243202000030001600010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>11.</b>&nbsp; Guti&eacute;rrez JM, Varona JL. An&aacute;lisis     de la posible evoluci&oacute;n de la epidemia de coronavirus COVID-19 por medio de un     modelo SEIR. Departamento de Matem&aacute;ticas y Computaci&oacute;n Universidad de La Rioja.     2020</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312698&pid=S2664-3243202000030001600011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>12.</b>&nbsp; V&aacute;zquez M, Shin HH, Luis J, Noguera     V. Simulaciones con el modelo SEIR del comportamiento epid&eacute;mico del COVID-19 en     el departamento de Guair&aacute;-Paraguay Passive Cooling Systems View project     Proyecto View project. 2020;(March):1&ndash;6. Available from: https://www</font></p>       <!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>13.</b>&nbsp; &Aacute;vila R. Inferencia de modelos     epidemeol&oacute;gicos compartimentales en redes sociales. 2016</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312700&pid=S2664-3243202000030001600013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>14.&nbsp; </b>De Mora A. ECON&Oacute;MICAS Y EMPRESARIALES GRADO EN ECONOM&Iacute;A Ecuaciones diferenciales ordinarias en la modelizaci&oacute;n de     procesos demogr&aacute;ficos naturales. Universidad de Sevilla; 2015</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312701&pid=S2664-3243202000030001600014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>15.</b>&nbsp;&nbsp; Ridenhour B, Kowalik JM, Shay DK.     Public Health Applications. Am J Public Heal [Internet]. 2015;104(2):32&ndash;41.     Available from: <a href="http://www.ajph.org" target="_blank">http://www.ajph.org</a></font></p>       ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>16.</b> Castro P, De los Reyes, JC, Gonz&aacute;lez S, Merino P, Ponce J. Modelizaci&oacute;n y     simulaci&oacute;n de la propagaci&oacute;n del virus sars-cov-2 en Ecuador. Modemat. 2020.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312703&pid=S2664-3243202000030001600016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>17.</b> Arroyo MG. Modelizaci&oacute;n y simulaci&oacute;n en epidemiolog&iacute;a. Fac CIENCIAS     MATEM&Aacute;TICAS Univ Complut MADRID. 2017</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312704&pid=S2664-3243202000030001600017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>18.</b>&nbsp;&nbsp; Garc L, Tutora R, Rodr IM. Modelos     matem&aacute;ticos compartimentales en epidemiolog&iacute;a. 2017</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312705&pid=S2664-3243202000030001600018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>19.</b>&nbsp;&nbsp; Njambi A. Comparing different     approaches of epidemiological modeling. Lappeenranta University of Technology;     2018</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312706&pid=S2664-3243202000030001600019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>20.</b> Hill A. Modelado de la propagaci&oacute;n de COVID-19 frente a la capacidad de     atenci&oacute;n&nbsp; m&eacute;dica&nbsp;&nbsp; [Internet].2020&nbsp; [cited &nbsp;2020 &nbsp;Sep &nbsp;&nbsp;&nbsp;19].     &nbsp;&nbsp;Available&nbsp; &nbsp;from: <a href="https://alhill.shinyapps.io/COVID19seir/" target="_blank">https://alhill.shinyapps.io/COVID19seir/</a> </font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312707&pid=S2664-3243202000030001600020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>21.</b>&nbsp;&nbsp; Picardo O. Cercos Epidemiol&oacute;gicos     Inteligentes: Un enfoque educativo, informacional y tecnol&oacute;gico. Instituto &nbsp;de Ciencia T e, (ICTI) I,     editors. &nbsp;El Salvador; 2020</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312708&pid=S2664-3243202000030001600021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>22.&nbsp;&nbsp; </b>Casas J. Clinical characteristics of patients     hospitalized with COVID-19 in Spain: results from the SEMICOVID-19 Network.     medRxiv. 2020</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312709&pid=S2664-3243202000030001600022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>23.</b>&nbsp;&nbsp; Guti&eacute;rrez-Aguilar R, C&oacute;rdova-Lepe     F, Mu&ntilde;oz-Quezada MT, Guti&eacute;rrez-Jara JP. Modelo de umbral de     reducci&oacute;n de tasa diaria de casos COVID-19 para evitar el colapso hospitalario     en Chile. Medwave [Internet]. 2020 Apr 8 [cited 2020 Nov     2];20(3):e7871. Available from: /link.cgi/Medwave/Revisiones/Analisis/7871.act</font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">         &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1312710&pid=S2664-3243202000030001600023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><br>           <br>     </font>         ]]></body>
<body><![CDATA[<p align="justify">         <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">    <br>            </font>       ]]></body>
<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Clinical and pathological characteristics of 2019 novel coronavirus disease ( COVID-19 ): a systematic reviews.]]></article-title>
<source><![CDATA[medRxiv]]></source>
<year>2020</year>
<page-range>1-31</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siordia]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiology and clinical features of COVID-19: A review of current literature]]></article-title>
<source><![CDATA[J Clin Virol Internet.]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortiz-Prado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Clinical, molecular and epidemiological characterization of the SARS-CoV2 virus and the Coronavirus disease 2019 (COVID-19), a comprehensive literature review]]></source>
<year>2020</year>
<month> M</month>
<day>ay</day>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[J Infect Internet.]]></source>
<year>2020</year>
<volume>80</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>656-65</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rothan]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<source><![CDATA[The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak]]></source>
<year>2020</year>
<publisher-name><![CDATA[J Autoimmun Internet]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rafiq]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[hree months of COVID-19: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Rev Med Virol]]></source>
<year>2020</year>
<month>;(</month>
<day>Ap</day>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Enfermedad del coronavirus 2019 Internet]]></source>
<year>2020</year>
<month> J</month>
<day>un</day>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Lancet (London, England)]]></source>
<year>2020</year>
<volume>6736</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>1-15</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mayr]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[measures to control COVID-19&#8239;: a rapid review]]></article-title>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Iberoamericano CC</collab>
<source><![CDATA[¿Qué ofrecen los modelos matemáticos para estimar la necesidad de hospitalización y/o tratamiento en las unidades de cuidados intensivos debido a la COVID-19?]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Análisis de la posible evolución de la epidemia de coronavirus COVID-19 por medio de un modelo SEIR.]]></source>
<year>2020</year>
<publisher-name><![CDATA[Departamento de Matemáticas y Computación Universidad de La Rioja]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Simulaciones con el modelo SEIR del comportamiento epidémico del COVID-19 en el departamento de Guairá-Paraguay Passive Cooling Systems View project Proyecto View project.]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ávila]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Inferencia de modelos epidemeológicos compartimentales en redes sociales]]></article-title>
<source><![CDATA[]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Mora]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[ECONÓMICAS Y EMPRESARIALES GRADO EN ECONOMÍA Ecuaciones diferenciales ordinarias en la modelización de procesos demográficos naturales.]]></source>
<year>2015</year>
<publisher-name><![CDATA[Universidad de Sevilla]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ridenhour]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Public Health Applications]]></article-title>
<source><![CDATA[Public Heal Internet]]></source>
<year>2015</year>
<volume>104</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Modelización y simulación de la propagación del virus sars-cov-2 en Ecuador]]></source>
<year></year>
<publisher-name><![CDATA[Modemat]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arroyo]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<source><![CDATA[Modelización y simulación en epidemiología]]></source>
<year></year>
<publisher-name><![CDATA[Fac CIENCIAS MATEMÁTICAS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garc]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Modelos matemáticos compartimentales en epidemiología]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Njambi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparing different approaches of epidemiological modeling. Lappeenranta University of Technology]]></article-title>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Modelado de la propagación de COVID-19 frente a la capacidad de atención médica]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Picardo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Cercos Epidemiológicos Inteligentes: Un enfoque educativo, informacional y tecnológico. Instituto de Ciencia T e, (ICTI) I, editors.]]></article-title>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>Casas J.</collab>
<source><![CDATA[Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMICOVID-19]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez-Aguilar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Modelo de umbral de reducción de tasa diaria de casos COVID-19 para evitar el colapso hospitalario en Chile]]></article-title>
<source><![CDATA[Medwave]]></source>
<year>2020</year>
<month> A</month>
<day>pr</day>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e7871</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
